About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
57121 genotypes with 273958 annotations displayed of selected term and subterms
Searched Term: mammalian phenotype
Allelic Composition
(Genetic Background)
Annotated Term Reference
7a6ex/7a6ex
(involves: C3HeB/FeJ * C57BL/6J)
complete embryonic lethality during organogenesis J:98216
decreased forebrain size J:98216
exencephaly J:98216
12aex/12aex
(involves: C3HeB/FeJ * C57BL/6J)
complete perinatal lethality J:98216
exencephaly J:98216
31bex/31bex
(involves: C3HeB/FeJ * C57BL/6J)
complete embryonic lethality during organogenesis J:98216
decreased forebrain size J:98216
exencephaly J:98216
38dlp/38dlp
(involves: C3HeB/FeJ * C57BL/6J)
abnormal lateral plate mesoderm morphology J:98216
abnormal somite development J:98216
complete embryonic lethality during organogenesis J:98216
embryonic growth arrest J:98216
97c2/97c2
(involves: C3HeB/FeJ * C57BL/6J)
complete perinatal lethality J:98216
exencephaly J:98216
open neural tube J:98216
917M/917M
(involves: C3H * C57BL/6J)
decreased compact bone thickness J:99483
917M/917M+
(C57BL/6-917M)
abnormal bone structure J:99483, J:132290
abnormal osteoblast physiology J:99483
abnormal tibia morphology J:99483
decreased bone mineral content J:99483
1110037F02Riktm1a(KOMP)Wtsi/?
(Not Specified)
embryonic lethality J:175295
preweaning lethality J:175295
1700011A15Riktm1a(KOMP)Wtsi/1700011A15Riktm1a(KOMP)Wtsi
(Not Specified)
decreased mean platelet volume J:175295
1700067K01Riktm2a(KOMP)Wtsi/?
(Not Specified)
preweaning lethality J:175295
1700112E06Riktm1e(EUCOMM)Wtsi/1700112E06Riktm1e(EUCOMM)Wtsi
(Not Specified)
decreased B cell number J:175295
increased NK T cell number J:175295
2010107G12Riktm1a(KOMP)Wtsi/2010107G12Riktm1a(KOMP)Wtsi
(Not Specified)
decreased body temperature J:175295
increased body temperature J:175295
2010111I01RikGt(GT411)Lmf/2010111I01RikGt(GT411)Lmf
(involves: 129P2/OlaHsd * MF1)
no abnormal phenotype detected J:152135
2210016L21Riktm1a(KOMP)Wtsi/?
(Not Specified)
abnormal hair follicle morphology J:175295
2210018M11RikGt(RRK255)Byg/2210018M11RikGt(RRK255)Byg
(B6;129P2-2210018M11RikGt(RRK255)Byg/Mmucd)
no phenotypic analysis J:94077
2210018M11RikGt(XH265)Byg/2210018M11RikGt(XH265)Byg
(B6;129P2-2210018M11RikGt(XH265)Byg/Mmucd)
no phenotypic analysis J:94077
2310007B03Riktm1a(KOMP)Wtsi/?
(Not Specified)
chromosomal instability J:175295
2310022B05Riktm1a(EUCOMM)Hmgu/2310022B05Riktm1a(EUCOMM)Hmgu
(Not Specified)
abnormal pupil morphology J:165965
corneal opacity J:165965
decreased circulating chloride level J:165965
decreased circulating sodium level J:165965
increased B cell number J:165965
increased leukocyte cell number J:165965
other phenotype J:165965
2310067B10Riktm1a(EUCOMM)Wtsi/2310067B10Rik+
(Not Specified)
increased mean corpuscular volume J:165965
2410089E03Rikb2b012Clo/2410089E03Rikb2b012Clo
(C57BL/6J-2410089E03Rikb2b012Clo)
abnormal sternum morphology J:175213
cleft palate J:175213
common atrium J:175213
complete atrioventricular septal defect J:175213
double outlet right ventricle J:175213
duplex kidney J:175213
kidney cysts J:175213
polydactyly J:175213
pulmonary artery hypoplasia J:175213
pulmonary hypoplasia J:175213
pulmonary valve atresia J:175213
right aortic arch J:175213
2410141K09RikGt(pU21)35Imeg/?
(involves: C57BL/6 * CBA)
no phenotypic analysis J:109358
2510003E04Riktm1a(KOMP)Wtsi/?
(Not Specified)
hemorrhage J:175295
hydrops fetalis J:175295
partial lethality J:175295
preweaning lethality J:175295
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor
(involves: 129S4/SvJaeSor)
abnormal frontal bone morphology J:117491
abnormal neurocranium morphology J:117491
abnormal skeleton morphology J:117491
abnormal snout morphology J:117491
abnormal sternum morphology J:117491
asymmetric rib-sternum attachment J:117491
increased fibroblast cell migration J:117491
partial prenatal lethality J:117491
short maxilla J:117491
short nasal bone J:117491
short premaxilla J:117491
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor
Pdgfratm1Sor/Pdgfra+

(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
abnormal ovary morphology J:142042
abnormal vascular smooth muscle morphology J:142042
anovulation J:142042
decreased circulating estradiol level J:142042
decreased corpora lutea number J:142042
decreased secondary ovarian follicle number J:142042
decreased thecal cell number J:142042
female infertility J:142042
small ovary J:142042
uterus hypoplasia J:142042
2610005L07RikGt(ROSA)73Sor/2610005L07RikGt(ROSA)73Sor
Pdgfratm2Sor/Pdgfra+

(involves: 129S4/SvJaeSor)
abnormal frontal bone morphology J:117491
abnormal skeleton morphology J:117491
abnormal snout morphology J:117491
short maxilla J:117491
short nasal bone J:117491
short premaxilla J:117491
2700049A03Riktm1.1Arte/2700049A03Riktm1.1Arte
Tg(Prrx1-cre)1Cjt/0

(involves: C57BL/6J * C57BL/6NTac * SJL/J)
abnormal carpal bone morphology J:175541
abnormal cell morphology J:175541
abnormal digit development J:175541
abnormal digit morphology J:175541
abnormal endochondral bone ossification J:175541
abnormal foot plate morphology J:175541
abnormal limb mesenchyme morphology J:175541
abnormal long bone epiphyseal plate morphology J:175541
abnormal skeleton development J:175541
brachydactyly J:175541
decreased fibroblast cell migration J:175541
decreased length of long bones J:175541
polydactyly J:175541
polysyndactyly J:175541
short femur J:175541
short fibula J:175541
short humerus J:175541
short limbs J:175541
short radius J:175541
short scapula J:175541
short tibia J:175541
short ulna J:175541
2700049A03Riktm1.2Arte/2700049A03Riktm1.2Arte
(either: (involves: C57BL/6NTac) or (involves: C57BL/6NTac * CD-1))
abnormal direction of heart looping J:175541
abnormal lateral nasal prominence morphology J:175541
abnormal left-right axis patterning J:175541
abnormal medial nasal prominence morphology J:175541
abnormal neural tube morphology/development J:175541
absent embryonic cilia J:175541
complete embryonic lethality during organogenesis J:175541
embryonic growth arrest J:175541
hemorrhage J:175541
narrow head J:175541
pericardial edema J:175541
2810004N23RikGt(pU21)55Imeg/?
(involves: C57BL/6 * CBA)
no phenotypic analysis J:109358
2810408A11Riktm1a(EUCOMM)Wtsi/2810408A11Riktm1a(EUCOMM)Wtsi
(Not Specified)
decreased T cell number J:165965
increased body weight J:165965
increased CD4-positive, alpha beta T cell number J:165965
increased NK cell number J:165965
limb grasping J:165965
2810417H13Riktm1.1Lkd/2810417H13Riktm1.1Lkd
(involves: C57BL/6)
abnormal common lymphocyte progenitor cell morphology J:177782
abnormal hematopoietic stem cell physiology J:177782
abnormal hematopoietic system physiology J:177782
decreased bone marrow cell number J:177782
decreased common myeloid progenitor cell number J:177782
decreased hematopoietic stem cell number J:177782
decreased leukocyte cell number J:177782
oxidative stress J:177782
spleen hypoplasia J:177782
thymus hypoplasia J:177782
2810417H13Riktm1.1Lkd/2810417H13Riktm1.1Lkd
Trp53tm1Tyj/Trp53+

(involves: 129S2/SvPas * C57BL/6)
increased hematopoietic stem cell number J:177782
2900026A02Riktm1a(EUCOMM)Hmgu/2900026A02Riktm1a(EUCOMM)Hmgu
(Not Specified)
abnormal eye morphology J:165965
abnormal retina morphology J:165965
3010026O09Riktm1a(EUCOMM)Wtsi/?
(Not Specified)
reduced male fertility J:175295
3110043O21Rikem1Rkuhn/3110043O21Rik+
(involves: C57BL/6 * DBA/2 * FVB/N)
no phenotypic analysis J:201579
4930591A17Riktm1a(KOMP)Wtsi/?
(Not Specified)
chromosomal instability J:175295
4930591A17Riktm1a(KOMP)Wtsi/4930591A17Riktm1a(KOMP)Wtsi
(Not Specified)
hypoactivity J:175295
increased lean body mass J:175295
4932438H23Riktm1a(EUCOMM)Wtsi/4932438H23Riktm1a(EUCOMM)Wtsi
(Not Specified)
abnormal vertebral arch morphology J:175295
4933402N03Riktm2a(KOMP)Wtsi/4933402N03Riktm2a(KOMP)Wtsi
(Not Specified)
abnormal cranium morphology J:175295
5830428H23RikGt(ROSA)76Sor/5830428H23Rik+
Arid5bGt(ROSA)75Sor/Arid5bGt(ROSA)75Sor

(involves: 129S4/SvJaeSor)
abnormal snout morphology J:117491
decreased body height J:117491
short maxilla J:117491
short nasal bone J:117491
short premaxilla J:117491
5830428H23RikGt(ROSA)76Sor/5830428H23RikGt(ROSA)76Sor
(involves: 129S4/SvJaeSor)
abnormal blood vessel morphology J:117491
abnormal cell migration J:117491
abnormal kidney morphology J:117491
abnormal kidney physiology J:117491
abnormal palate morphology J:117491
abnormal presphenoid bone morphology J:117491
abnormal renal glomerulus morphology J:117491
abnormal skeleton morphology J:117491
abnormal smooth muscle morphology J:117491
abnormal sternum morphology J:117491
abnormal vertebrae morphology J:117491
abnormal vertebral arch morphology J:117491
anemia J:117491
asymmetric rib-sternum attachment J:117491
decreased erythrocyte cell number J:117491
decreased hematocrit J:117491
decreased hemoglobin content J:117491
decreased palatine bone horizontal plate size J:117491
hemorrhage J:117491
increased blood urea nitrogen level J:117491
increased rib number J:117491
kidney inflammation J:117491
pale kidney J:117491
partial postnatal lethality J:117491
polychromatophilia J:117491
reticulocytosis J:117491
small kidney J:117491
5830428H23RikGt(ROSA)76Sor/5830428H23RikGt(ROSA)76Sor
Arid5bGt(ROSA)75Sor/Arid5bGt(ROSA)75Sor

(involves: 129S4/SvJaeSor)
abnormal skeleton morphology J:117491
absent palatine bone horizontal plate J:117491
cleft palate J:117491
complete neonatal lethality J:117491
5830428H23RikGt(ROSA)76Sor/5830428H23RikGt(ROSA)76Sor
Pdgfratm2Sor/Pdgfra+

(involves: 129S4/SvJaeSor)
abnormal frontal bone morphology J:117491
abnormal skeleton morphology J:117491
8430408G22Riktm1(EGFP/cre)Shin/8430408G22Riktm1(EGFP/cre)Shin
(involves: 129S1/Sv * C57BL/6)
no abnormal phenotype detected J:144155
9130011E15Riktm1a(EUCOMM)Wtsi/?
(Not Specified)
embryonic lethality J:175295
preweaning lethality J:175295
9630033F20RikGt(EUCE0047g05)Hmgu/9630033F20RikGt(EUCE0047g05)Hmgu
(involves: 129P2/OlaHsd)
abnormal small intestinal crypt cell physiology J:198650
abnormal small intestinal crypt cell proliferation J:198650
increased cellular sensitivity to alkylating agents J:198650
increased cellular sensitivity to gamma-irradiation J:198650
increased sensitivity to xenobiotic induced morbidity/mortality J:198650
increased small intestinal crypt cell apoptosis J:198650
increased susceptibility to induced colitis J:198650
oxidative stress J:198650
9630033F20RikGt(EUCE0047g05)Hmgu/9630033F20RikGt(EUCE0047g05)Hmgu
Apctm1Tno/Apctm1Tno
Lgr5tm1(cre/ERT2)Cle/Lgr5+

(involves: 129P2/OlaHsd * 129S4/SvJae)
decreased sensitivity to induced morbidity/mortality J:198650
decreased tumor growth/size J:198650
9630033F20Riktm1.1Khv/9630033F20Riktm1.1Khv
Tg(CMV-cre)1Cgn/0

(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * SJL)
increased susceptibility to induced colitis J:198650
9630033F20Riktm1.1Smat/9630033F20Rik+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JJcl)
no phenotypic analysis J:183674
9630033F20Riktm1.2Smat/9630033F20Riktm1.2Smat
Tg(CAG-EGFP/Map1lc3b)53Nmz/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JJcl * C57BL/6NCrj)
abnormal autophagy J:183674
abnormal heart morphology J:183674
abnormal mitochondrial chromosome morphology J:183674
abnormal mitochondrial physiology J:183674
altered response to myocardial infarction J:183674
decreased cardiomyocyte apoptosis J:183674
increased cardiac muscle contractility J:183674
oxidative stress J:183674
a/a
(involves: SM/J)
endocrine/exocrine gland phenotype J:19308
a/a
(Not Specified)
abnormal coat/hair pigmentation J:36414
darkened coat color J:36414
a/a
Bloc1s6pa/Bloc1s6pa

(involves: C57BL/6J)
abnormal retinal melanin granule morphology J:5346
a/a
Corintm1Bamo/Corintm1Bamo

(involves: 129X1/SvJ * C57BL/6 * FVB/N)
integument phenotype J:130426
a/a
Hps6ru/Hps6ru

(B6.Cg-Hps6ru)
abnormal coat/hair pigmentation J:6064
abnormal kidney physiology J:6422
abnormal lateral geniculate nucleus morphology J:6064
abnormal platelet dense granule number J:7327
abnormal retinal ganglion cell morphology J:6064
decreased platelet ADP level J:7327
decreased platelet ATP level J:7327
decreased platelet serotonin level J:29748, J:7327
decreased susceptibility to atherosclerosis J:29748
increased bleeding time J:7327
a/a
Hps6ru/Hps6ru

(Not Specified)
abnormal choroid pigmentation J:81444
abnormal eye pigment epithelium morphology J:81444
abnormal eye pigmentation J:13122, J:81444
abnormal iris pigmentation J:13122
decreased eye pigmentation J:13122
diluted coat color J:13122
hypopigmentation J:12970
a/a
Hps6ru/Hps6ru

(involves: C57BL/6J)
abnormal eye pigmentation J:5346
abnormal melanogenesis J:5346
abnormal melanosome morphology J:5346
a/a
Hps6ru/Hps6ru
Lystbg/Lystbg

(involves: C3H/Rl * C57BL/6J)
abnormal melanogenesis J:5346
abnormal melanosome morphology J:5346
abnormal retinal melanin granule morphology J:5346
a/a
KitW-2J/Kit+

(C57BL/6J)
white spotting J:192797
a/a
Lystbg/Lystbg

(involves: C3H/Rl * C57BL/6J)
abnormal choroid melanin granule morphology J:5346
abnormal retinal melanin granule morphology J:5346
a/a
Lystbg/Lystbg
Oca2p-J/Oca2p-J

(involves: C3H/HeJ * C3H/Rl * C57BL/6J)
abnormal choroid melanin granule morphology J:5346
abnormal melanosome morphology J:5346
a/a
Lystbg/Lystbg
Tyrc/Tyrc

(involves: C3H/Rl * C57BL/6J)
abnormal choroid melanin granule morphology J:5346
abnormal melanogenesis J:5346
abnormal melanosome morphology J:5346
abnormal retinal melanin granule morphology J:5346
a/a
Lystbg/Lystbg
Tyrp1b/Tyrp1b

(involves: C3H/Rl * C57BL/6J)
abnormal choroid melanin granule morphology J:5346
abnormal retinal melanin granule morphology J:5346
a/a
Mc1re/Mc1re
Pomctm1Sora/Pomctm1Sora
Tg(MC1R)1Jkn/?

(involves: 129S6/SvEvTac * C57BL/6Ha)
abnormal hair follicle pheomelanosome pheomelanin content J:129904
yellow coat color J:129904
a/a
Mlphln/Mlphln

(involves: C57BL/J * C57BR)
abnormal choroid melanin granule morphology J:5346
abnormal hair follicle melanin granule distribution J:5346
a/a
Mlphln/Mlphln

(Not Specified)
abnormal coat/hair pigmentation J:12970
abnormal hair follicle melanocyte morphology J:12970
abnormal hair shaft melanin granule distribution J:12970
diluted coat color J:12970
a/a
Mlphln/Mlphln
Tyrp1b/Tyrp1b

(C57L/J)
abnormal coat/hair pigmentation J:5095
abnormal melanocyte morphology J:5095
diluted coat color J:5095
a/a
Mregdsu/Mregdsu
Hps6ru/Hps6ru

(involves: C57BL/6J)
diluted coat color J:29467
phenotypic reversion J:29467
a/a
Mssq1KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq3KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq4KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq5C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq6C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq6KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq7KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq8C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq9C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq10KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq11KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq12KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq13C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq13KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq14KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq15C57BL/6JJcl/Mssq15KK/TaJcl

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Mssq16KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
a/a
Myo5ad/Myo5a+
Oca2p/Oca2+
Tyrp1B-lt/Tyrp1+

(involves: C58 * CT/Ch)
diluted coat color J:13094
a/a
Myo5ad/Myo5ad

(involves: DBA/2J)
abnormal choroid melanin granule morphology J:5346
abnormal hair follicle melanin granule distribution J:5346
a/a
Myo5ad/Myo5ad

(Not Specified)
abnormal coat/hair pigmentation J:12958
abnormal eye pigmentation J:12958
abnormal hair shaft melanin granule distribution J:12958
abnormal hair shaft morphology J:12958
abnormal melanocyte morphology J:12970
diluted coat color J:12958
a/a
Oca2p-J/Oca2p-J

(involves: C3H/HeJ)
abnormal choroid melanin granule morphology J:5346
abnormal melanogenesis J:5346
abnormal melanosome morphology J:5346
a/a
Oca2p/Oca2p

(Not Specified)
abnormal coat/hair pigmentation J:78801, J:12958
abnormal ear pigmentation J:78801
abnormal hair follicle melanin granule distribution J:12958
abnormal hair follicle melanin granule morphology J:12958
abnormal hair follicle melanin granule shape J:12958
abnormal hair follicle melanocyte morphology J:78801
abnormal skin pigmentation J:78801
decreased ear pigmentation J:36414
decreased eye pigmentation J:78801
decreased skin pigmentation J:36414
a/a
Rab27aash/Rab27aash

(involves: C3H/HeSnJ * C57BL/6J)
decreased platelet serotonin level J:77395
hematopoietic system phenotype J:77395
increased bleeding time J:77395
a/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+

(involves: C57BL/6 * KK)
behavior/neurological phenotype J:168271
decreased body weight J:168271
decreased circulating glucose level J:168271
decreased gonadal fat pad weight J:168271
decreased liver weight J:168271
improved glucose tolerance J:168271
a/a
Tyrc-i/Tyrc-i

(involves: STOCK Tyrc-r)
abnormal coat/hair pigmentation J:83666
diluted coat color J:83666
a/a
Tyrc/Tyrc

(involves: C57BL/6J)
abnormal melanogenesis J:5346
a/a
Tyrp1B-lt/Tyrp1+

(Not Specified)
abnormal dorsoventral coat patterning J:13094
abnormal hair shaft melanin granule distribution J:13094
abnormal hair shaft melanin granule morphology J:13094
reduced hair shaft melanin granule number J:13094
a/a
Tyrp1B-lt/Tyrp1B-lt

(Not Specified)
abnormal dorsoventral coat patterning J:13094
abnormal hair follicle melanin granule morphology J:13094
abnormal hair shaft melanin granule distribution J:13094
abnormal hair shaft melanin granule morphology J:13094
enlarged hair follicle melanin granules J:13094
reduced hair shaft melanin granule number J:13094
a/a
Tyrp1b/Tyrp1b

(involves: C57BL/6J)
abnormal melanosome morphology J:5346
a/a
Tyrp1b/Tyrp1b

(Not Specified)
abnormal coat/hair pigmentation J:12970
abnormal eye pigmentation J:12970
abnormal melanocyte morphology J:12970
a/a
Tyrp1b/Tyrp1b
wad/wad

(Not Specified)
diluted coat color J:162146
a/a
Tyrp1b/Tyrp1b
wad/wad+

(Not Specified)
diluted coat color J:162146
a/a
U/U

(Not Specified)
abnormal coat/hair pigmentation J:78801
darkened coat color J:78801
a/a
Zc3h4KK/Zc3h4KK

(involves: C57BL/6J * KK-Ay)
increased body weight J:48704
a/A
Mc1re/Mc1re
Pomctm1Sora/Pomctm1Sora
Tg(MC1R)1Jkn/?

(involves: 129S6/SvEvTac * C57BL/6Ha)
abnormal hair follicle pheomelanosome pheomelanin content J:129904
yellow coat color J:129904
a/A
Pomctm1Sora/Pomctm1Sora

(involves: 129S6/SvEvTac)
abnormal hair follicle pheomelanosome pheomelanin content J:129904
yellow coat color J:129904
a/a6H
(involves: 101/H * C3H/HeH)
abnormal pinna hair pigmentation J:5021
darkened coat color J:5021
a/a13H
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:90559
a/a17H
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:90559
a/a19H
(involves: C3H/HeH)
abnormal coat/hair pigmentation J:90559
a/a20H
(Not Specified)
abnormal coat/hair pigmentation J:90559
a/atwp
(Not Specified)
abnormal coat/hair pigmentation J:16568
abnormal ventral coat pigmentation J:16568
a/Aw-20J
(C57BL/6J)
abnormal coat/hair pigmentation J:79402
abnormal ventral coat pigmentation J:79402
a/Aw-22J
(C57BL/10Rk)
abnormal coat/hair pigmentation J:79402
abnormal ventral coat pigmentation J:79402
a/Ay
Bwq2KK/Bwq2KK

(involves: C57BL/6J * KK-Ay)
increased body weight J:131439, J:93199
increased susceptibility to weight gain J:93199
a/Ay
Bwq10C57BL/6J/Bwq10C57BL/6J

(involves: C57BL/6J * KK-Ay)
increased body weight J:131439
a/Ay
Guq1KK/Guq1KK

(involves: C57BL/6J * KK-Ay)
increased urine glucose level J:131439
a/Ay
Guq2C57BL/6J/Guq2C57BL/6J

(involves: C57BL/6J * KK-Ay)
increased urine glucose level J:131439
a/Ay
Zc3h4C57BL/6J/Zc3h4KK

(involves: C57BL/6J * KK-Ay)
increased body weight J:48704
a/Ay
Zc3h4KK/Zc3h4KK

(involves: C57BL/6J * KK-Ay)
increased body weight J:131439, J:48704
A/?
Lystbg/Lystbg
Tyrp1+/?

(Not Specified)
abnormal eye pigmentation J:29744
decreased ear pigmentation J:29744
decreased tail pigmentation J:29744
diluted coat color J:29744
irregular coat pigmentation J:29744
A/?
Lystbg/Lystbg
Tyrp1b/Tyrp1b

(Not Specified)
decreased eye pigmentation J:29744
diluted coat color J:29744
A/a
Tyrp1B-lt/Tyrp1B-lt

(Not Specified)
diluted coat color J:13094
A/A
(Not Specified)
no abnormal phenotype detected J:36414
pigmentation phenotype J:36414
A/A
Dkd/Dkd

(LPT;C3-Dkd/GrsrJ)
abnormal dorsoventral coat patterning J:137334
hearing/vestibular/ear phenotype J:137334
vision/eye phenotype J:137334
A/A
Hps6ru/Hps6ru

(Not Specified)
diluted coat color J:13122
A/A
Tyrc-ch/Tyrc-ch

(Not Specified)
abnormal coat appearance J:36414
abnormal coat/hair pigmentation J:36414
abnormal hair follicle pheomelanosome pheomelanin content J:36414
A/A
U/U

(Not Specified)
abnormal coat/hair pigmentation J:78801
darkened coat color J:78801, J:280
A/atl
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:169366
A/atwp
(Not Specified)
abnormal coat/hair pigmentation J:16568
abnormal ventral coat pigmentation J:16568
A1cftm1Ddsn/A1cftm1Ddsn
(involves: 129X1/SvJ)
complete embryonic lethality before implantation J:114732
decreased cell proliferation J:114732
A2mtm1Vln/A2m+
(involves: 129P2/OlaHsd * C57BL)
no abnormal phenotype detected J:28328
A2mtm1Vln/A2mtm1Vln
(involves: 129P2/OlaHsd * C57BL)
abnormal bile color J:28328
decreased susceptibility to weight gain J:28328
disheveled coat J:28328
enlarged liver J:28328
gallstones J:28328
greasy coat J:28328
hepatic steatosis J:28328
homeostasis/metabolism phenotype J:28328
hypoactivity J:28328
increased sensitivity to induced morbidity/mortality J:28328
increased susceptibility to induced pancreatitis J:28328
liver/biliary system phenotype J:28328
pancreas inflammation J:28328
respiratory system phenotype J:28328
tumorigenesis J:28328
A2mtm1Vln/A2mtm1Vln
(B.129P2-A2mtm1Vln)
abnormal circulating enzyme level J:57485
abnormal cytokine level J:57485
abnormal enzyme/coenzyme activity J:57485
abnormal pancreatic acinar cell morphology J:57485
abnormal pancreatic acinus morphology J:57485
hepatic necrosis J:57485
increased sensitivity to induced morbidity/mortality J:57485
liver inflammation J:57485
A2mtm1Vln/A2mtm1Vln
(B6.129P2-A2mtm1Vln)
abnormal cytokine secretion J:113532
homeostasis/metabolism phenotype J:113532
impaired febrile response J:113532
A3galt2tm1.1Hjg/A3galt2tm1.1Hjg
(involves: 129P2/OlaHsd * BALB/cJ)
immune system phenotype J:120323
no abnormal phenotype detected J:120323
A4galttm1.1Poru/A4galttm1.1Poru
Glatm1Kul/Glatm1Kul

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
immune system phenotype J:189359
A4galttm1Kfk/A4galttm1Kfk
(involves: C57BL/6)
decreased physiological sensitivity to xenobiotic J:108352
decreased sensitivity to xenobiotic induced morbidity/mortality J:108352
impaired behavioral response to xenobiotic J:108352
A4gnttm1Jnaka/A4gnttm1Jnaka
(B6.129S6-A4gnttm1Jnaka)
abnormal digestive system physiology J:184485
abnormal stomach mucosa morphology J:184485
increased angiogenesis J:184485
increased cell proliferation J:184485
increased gastric adenocarcinoma incidence J:184485
increased tumor growth/size J:184485
stomach epithelial hyperplasia J:184485
stomach inflammation J:184485
A830080D01RikGt(P078F05)Wrst/Y
(chimera involves: 129S2/SvPas)
no abnormal phenotype detected J:160967
A830080D01RikGt(W069B04)Wrst/Y
(chimera involves: 129S2/SvPas)
no abnormal phenotype detected J:160967
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
(involves: 129S6/SvEvTac)
abnormal cone electrophysiology J:179784
abnormal hippocampus granule cell morphology J:179784
abnormal retinal apoptosis J:179784
abnormal retinal cone cell morphology J:179784
decreased brain size J:179784
decreased brain weight J:179784
decreased retinal cone cell number J:179784
increased neuron apoptosis J:179784
limb grasping J:179784
nervous system phenotype J:179784
partial postnatal lethality J:179784
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
Tg(Crx-DsRed,-Mir124a-2)#Tfur/0

(involves: 129S6/SvEvTac * C3H * C57BL/6)
vision/eye phenotype J:179784
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
Tg(Syn1-DsRed,-Mir124a-2)#Tfur/0

(involves: 129S6/SvEvTac * C3H * C57BL/6)
nervous system phenotype J:179784
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
(involves: 129S6/SvEvTac)
abnormal cone electrophysiology J:179784
abnormal hippocampus granule cell morphology J:179784
abnormal retinal apoptosis J:179784
abnormal retinal cone cell morphology J:179784
decreased brain size J:179784
decreased brain weight J:179784
decreased retinal cone cell number J:179784
increased neuron apoptosis J:179784
limb grasping J:179784
nervous system phenotype J:179784
partial postnatal lethality J:179784
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
Tg(Crx-DsRed,-Mir124a-2)#Tfur/0

(involves: 129S6/SvEvTac * C3H * C57BL/6)
vision/eye phenotype J:179784
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
Tg(Syn1-DsRed,-Mir124a-2)#Tfur/0

(involves: 129S6/SvEvTac * C3H * C57BL/6)
nervous system phenotype J:179784
a1R/a1R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a2R/a2R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a3R/a3R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a4R/a4R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a5mnu/a5mnu
(involves: 101/H * C3H/HeH)
abnormal coat appearance J:16567
darkened coat color J:16567
a5R/a5R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a6H/a6H
(involves: 101/H * C3H/HeH)
abnormal pinna hair pigmentation J:5021
darkened coat color J:5021
a6R/a6R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a7R/a7R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a8R/a8R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a9R/a9R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a10R/a10R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a11R/a11R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a12R/a12R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a13H/a13H
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:90559
abnormal pinna hair pigmentation J:90559
a13R/a13R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a14R/a14R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a15R/a15R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a16H/a16H
(involves: 101/H * C3H/HeH)
prenatal lethality J:8093
a16H/ae
(involves: 101/H * C3H/HeH * P * S)
abnormal coat/hair pigmentation J:8093
a16H/al
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:9799
a16R/a16R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a17H/a17H
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:90559
abnormal pinna hair pigmentation J:90559
a17R/a17R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a18R/a18R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a19H/a19H
(involves: C3H/HeH)
abnormal coat/hair pigmentation J:90559
abnormal pinna hair pigmentation J:90559, J:181531
a19R/a19R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a20H/a20H
(Not Specified)
abnormal coat/hair pigmentation J:90559
abnormal pinna hair pigmentation J:90559
abnormal tail hair pigmentation J:90559
a20R/a20R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a21R/a21R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a22R/a22R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a23R/a23R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a24R/a24R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
a25R/a25R
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:100221
ada/ada
(involves: 101/H * C3H/HeH)
abnormal dorsoventral coat patterning J:13694
abnormal pinna hair pigmentation J:163587
darkened coat color J:13694
ae/ae
((P x S)F1)
abnormal coat/hair pigmentation J:13070
darkened coat color J:13070
ae/ae
Tbx15de-H/Tbx15de-H

(involves: BTBR * C3H/HeJ * C57BL/6 * P * S)
abnormal skeleton morphology J:87455
abnormal skin pigmentation J:87455
decreased body size J:87455
integument phenotype J:87455
short hair J:87455
Agsfdcc4/Agsfdcc4
(C3HeB/FeJ)
darkened coat color J:81301
Ahvy/A
(C3H/HeJ)
abnormal coat/hair pigmentation J:24247
darkened coat color J:24247
irregular coat pigmentation J:24247
yellow coat color J:24247
Ahvy/Ahvy
(C3H/HeJ)
abnormal coat/hair pigmentation J:24247
Aiapy/?
(involves: C3H/HeJ * C57BL/6J)
abnormal coat/hair pigmentation J:18848
irregular coat pigmentation J:18848
maternal effect J:18848
mottled coat J:18848
obese J:18848
yellow coat color J:18848
Aiapy/Aiapy
(involves: C3H/HeJ * C57BL/6J)
abnormal coat/hair pigmentation J:18848
irregular coat pigmentation J:18848
mortality/aging J:18848
mottled coat J:18848
obese J:18848
yellow coat color J:18848
Aiy/A
(C3H/HeJ-Aiy)
abnormal coat/hair pigmentation J:30922
mottled coat J:30922
obese J:30922
yellow coat color J:30922
Aiy/Aiy
(C3H/HeJ-Aiy)
abnormal coat/hair pigmentation J:30922
mottled coat J:30922
obese J:30922
yellow coat color J:30922
ajIs(17;In2)1Gso/ajIs(17;In2)1Gso
Fmn1ld-Is(17;In2)1Gso/Fmn1ld-Is(17;In2)1Gso

(involves: 101/Rl * C3H/Rl * C57BL/E * SEC/Rl)
abnormal autopod morphology J:10399
abnormal carpal bone morphology J:10399
abnormal forelimb morphology J:10399
abnormal hindlimb morphology J:10399
abnormal patella morphology J:10399
abnormal radius morphology J:10399
abnormal tarsal bone morphology J:10399
abnormal ulna morphology J:10399
absent fibula J:10399
brachydactyly J:10399
darkened coat color J:10399
dilated ureter J:10399
fused carpal bones J:10399
fused tarsal bones J:10399
hydronephrosis J:10399
hydroureter J:10399
oligodactyly J:10399
radius hypoplasia J:10399
renal hypoplasia J:10399
single kidney J:10399
syndactyly J:10399
synostosis J:10399
ajl10/a
(Not Specified)
darkened coat color J:16567
ajl10/ajl10
(Not Specified)
prenatal lethality J:16567
ajl41/a
(Not Specified)
darkened coat color J:16567
ajl41/ajl41
(Not Specified)
prenatal lethality J:16567
ajl85/a
(Not Specified)
darkened coat color J:16567
ajl85/ajl85
(Not Specified)
prenatal lethality J:16567
al/a
(involves: 101/H * C3H/HeH)
pigmentation phenotype J:9799
al/al
(involves: 101/H * C3H/HeH)
prenatal lethality J:9799
am-J/a
(involves: C3H/HeJ * C57BL/6J)
mottled coat J:16570
am-J/am-J
(involves: C3H/HeJ * C57BL/6J)
maternal imprinting J:16570
mottled coat J:16570
am/a
(involves: 101/Rl * C3H/Rl)
irregular coat pigmentation J:29504, J:5964
maternal effect J:5964
mottled coat J:29504
Asy/a
(C57BL/6J)
yellow coat color J:13497
Asy/Asy
(C57BL/6J)
yellow coat color J:13497
at-2Gso/at-2Gso
(involves: C57BL/RlGso * SEC/RlGso)
abnormal coat/hair pigmentation J:3523
at-33J/at-33J
(C57BL/6J-at-33J/J)
abnormal dorsoventral coat patterning J:78801
at-41J/at-41J
(involves: AKR/J * C57L/J)
abnormal coat appearance J:78801, J:30778
abnormal ventral coat pigmentation J:30778
at-42J/?
(C57BL/6J-at-42J)
abnormal coat/hair pigmentation J:8876
abnormal ventral coat pigmentation J:78379
at-43J/at-43J
(involves: C3HeB/FeJLe)
abnormal coat appearance J:78801, J:30778
abnormal ventral coat pigmentation J:30778
at-44J/?
(B6.C/(HZ18)By)
abnormal coat/hair pigmentation J:78379
abnormal ventral coat pigmentation J:78379
at/A
As/As+

(Not Specified)
abnormal coat/hair pigmentation J:5027
at/at
(Not Specified)
abnormal coat/hair pigmentation J:78801
abnormal dorsoventral coat patterning J:78801, J:22600
at/at
As/As

(Not Specified)
abnormal coat/hair pigmentation J:5027
darkened coat color J:5027
at/at
Tbx15de-H/Tbx15de-H

(involves: BTBR * C3H/HeJ * C57BL/6)
abnormal dorsoventral coat patterning J:87455
abnormal ventral coat pigmentation J:87455
broad nasal bridge J:87455
decreased body size J:87455
irregular coat pigmentation J:87455
lowered ear position J:87455
narrow eye opening J:87455
ocular hypertelorism J:87455
shortened head J:87455
at/atl
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:169366
atd/a
(C57BL/6J-atd/J)
abnormal coat/hair pigmentation J:13082
abnormal dorsoventral coat patterning J:13082
abnormal ventral coat pigmentation J:13082
atd/atd
(C57BL/6J-atd/J)
abnormal coat/hair pigmentation J:13082
abnormal dorsoventral coat patterning J:13082
abnormal ventral coat pigmentation J:13082
atl/atl
(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:169366
darkened coat color J:169366
Atm1.1Arte/a
(C57BL/6NTac-Atm1.1Arte/a)
integument phenotype J:213411
phenotypic reversion J:213411
pigmentation phenotype J:213411
Atm1.1Arte/Atm1.1Arte
Tyrtm1Arte/Tyrtm1Arte

(C57BL/6NTac-Atm1.1Arte Tyrtm1Arte)
absent coat pigmentation J:213411
absent eye pigmentation J:213411
Atm1Brd/a
(C57BL/6N-Atm1Brd/a)
integument phenotype J:149352
pigmentation phenotype J:149352
Atm1Brd/Atm1Brd
(C57BL/6N-Atm1Brd)
integument phenotype J:149352
pigmentation phenotype J:149352
atwp/atwp
(involves: AB/Hum-1)
abnormal coat/hair pigmentation J:16568
abnormal ventral coat pigmentation J:16568
au/a
((C3H/HeH x 101/H)F1)
abnormal coat/hair pigmentation J:13694
au/au
((C3H/HeH x 101/H)F1)
abnormal coat/hair pigmentation J:13694
Avy/?
(129S1.C3-Avy)
tumorigenesis J:146879
Avy/a
(involves: C3H/HeJ * C57BL/6)
abnormal coat/hair pigmentation J:117156
abnormal epigenetic regulation of gene expression J:117156
increased tumor incidence J:117156
obese J:117156
variegated coat color J:117156
Avy/a
(involves: C57BL/6J)
abnormal epigenetic regulation of gene expression J:82396
variegated coat color J:82396
Avy/a
Axin1Fu/Axin1+

(involves: 129P4/RrRk * C67BL/6J)
genetic imprinting J:82396
Avy/A
Dnmt1MommeD2/Dnmt1+

(involves: C57BL/6J * FVB/NJ)
yellow coat color J:99816
Avy/A
Smarca5MommeD4/Smarca5+

(involves: C57BL/6J * FVB/NJ)
mottled coat J:99816
Avy/A
Smchd1MommeD1/Smchd1+

(involves: C57BL/6J * FVB/NJ)
yellow coat color J:99816
Avy/Avy
(involves: C3H/HeJ)
abnormal coat/hair pigmentation J:13080
Avy/Aw
(129S1.C3-Avy/Aw Chr 19MOLF/Ei)
tumorigenesis J:146879
Aw-15J/a
(involves: C57BL/6J * DBA/2J)
abnormal coat/hair pigmentation J:78474
abnormal ventral coat pigmentation J:78474
Aw-26J/a
(C57BL/6J)
abnormal coat/hair pigmentation J:78801
abnormal ventral coat pigmentation J:78801
Aw-27J/a
(C57BL/6J)
abnormal coat/hair pigmentation J:78801
abnormal ventral coat pigmentation J:78801
Aw-34J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-35J/?
(involves: C57BL)
absent coat pigmentation J:16984
Aw-36J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-37J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-38J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-39J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-40J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-41J/?
(involves: C57BL)
absent coat pigmentation J:16984
Aw-42J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-43J/?
(involves: C57BL/6J)
absent coat pigmentation J:16984
Aw-46J/a
(C57BL/6J)
abnormal coat/hair pigmentation J:77218
abnormal skin pigmentation J:77218
Aw-46J/Aw-46J
(C57BL/6J)
abnormal coat/hair pigmentation J:77218
abnormal skin pigmentation J:77218
Aw-47J/A
(C57BL/6J)
abnormal coat/hair pigmentation J:77218
abnormal skin pigmentation J:77218
Aw-47J/Aw-47J
(C57BL/6J)
abnormal coat/hair pigmentation J:77218
abnormal skin pigmentation J:77218
Aw-J/Aw-J
(C57BL/6J-Aw-J/J)
abnormal hair follicle melanogenesis J:1295
abnormal ventral coat pigmentation J:30922
decreased circulating pituitary hormone level J:52183
Aw/?
(Not Specified)
abnormal ventral coat pigmentation J:78801, J:22600
yellow coat color J:22600
Aw/a
(involves: SM/J)
endocrine/exocrine gland phenotype J:19308
Aw/a
Corintm1Bamo/Corintm1Bamo

(involves: 129X1/SvJ * C57BL/6 * FVB/N)
diluted coat color J:130426
Aw/at
As/As+

(Not Specified)
abnormal coat/hair pigmentation J:5027
Aw/Aw
(involves: SM/J)
abnormal x-zone morphology J:19308
endocrine/exocrine gland phenotype J:19308
Aw/Aw
As/As

(involves: 101/H * C3H/HeH)
abnormal coat/hair pigmentation J:5027
darkened coat color J:5027
Aw/Aw
Corintm1Bamo/Corintm1Bamo

(involves: 129X1/SvJ * C57BL/6 * FVB/N)
diluted coat color J:130426
ax/a
(involves: 101/Rl * C3H/Rl)
abnormal coat/hair pigmentation J:174047
abnormal ventral coat pigmentation J:174047
ax/a
(B6.Cg-ax)
abnormal coat/hair pigmentation J:11953
abnormal ventral coat pigmentation J:11953
complete embryonic lethality J:11953
embryonic lethality between implantation and placentation J:11953
ax/ae
(B6.Cg-ax)
abnormal coat/hair pigmentation J:11953
abnormal ventral coat pigmentation J:11953
ax/ax
(B6.Cg-ax)
complete embryonic lethality between implantation and placentation J:11953
embryonic growth retardation J:11953
ax/ax
(involves: 101/Rl * C3H/Rl)
embryonic lethality J:174047
Ay-J/?
(C3HeB/FeJ)
yellow coat color J:78380
Ay-Jkn/A
(involves: C57BL/6N)
yellow coat color J:129904
Ay-Jkn/A
Mc1re/Mc1re

(involves: C57BL/6Ha * C57BL/6N)
yellow coat color J:129904
Ay-Jkn/A
Mc1re/Mc1re
Tg(MC1R)1Jkn/0

(involves: C57BL/6Ha * C57BL/6N)
yellow coat color J:129904
Ay/a
(involves: KK)
abnormal lipid homeostasis J:26460
abnormal pancreatic islet morphology J:26460
abnormal renal glomerulus morphology J:26460
abnormal renal tubule morphology J:26460
degranulated pancreatic beta cells J:26460
dilated renal tubules J:26460
expanded mesangial matrix J:26460
hyperglycemia J:26460
impaired glucose tolerance J:26460
increased circulating insulin level J:26460
increased renal glomerulus basement membrane thickness J:26460
increased susceptibility to weight gain J:26460
increased total body fat amount J:26460
increased urine glucose level J:26460
insulin resistance J:26460
renal cast J:26460
Ay/a
(B6.Cg-Ay/J)
abnormal food intake J:102986
abnormal hair follicle melanogenesis J:1295
Ay/a
Agrptm2(DTR)Rpa/Agrp+

(involves: 129S4/SvJaeSor * KK/Upj)
abnormal eating behavior J:132184
decreased body weight J:132184
Ay/a
Apoetm1Unc/Apoetm1Unc

(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
abnormal glomerular mesangium morphology J:177084
abnormal inflammatory response J:177084
abnormal kidney morphology J:177084
atherosclerotic lesions J:177084
decreased adiponectin level J:177084
glomerulosclerosis J:177084
hyperglycemia J:177084
increased circulating cholesterol level J:177084
increased circulating insulin level J:177084
increased circulating leptin level J:177084
increased circulating triglyceride level J:177084
increased monocyte cell number J:177084
insulin resistance J:177084
obese J:177084
Ay/a
Apoetm1Unc/Apoetm1Unc
Ccr2tm1Mae/Ccr2tm1Mae

(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
decreased adiponectin level J:177084
homeostasis/metabolism phenotype J:177084
increased circulating cholesterol level J:177084
increased circulating leptin level J:177084
Ay/a
Dmbx1tm1Sse/Dmbx1tm1Sse

(involves: ICR)
decreased body weight J:125193
Ay/a
Ednrbs/Ednrbs

(Not Specified)
variable body spotting J:12954
Ay/a
Mssq1KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq2C57BL/6JJcl/Mssq2KK/TaJcl

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq3KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq4KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq5C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq6C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq6KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq7KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq9C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq10KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq11KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq12KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq13C57BL/6JJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq13KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq14KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Mssq16KK/TaJcl/?

(involves: C57BL/6JJcl * KK/TaJcl)
abnormal mandible morphology J:143893
Ay/a
Npbwr1tm1Rck/Npbwr1tm1Rck

(involves: 129P/Ola * C57BL/6J)
obese J:94820
Ay/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+

(involves: C57BL/6 * KK)
abnormal eating behavior J:168271
adipose tissue phenotype J:168271
decreased body weight J:168271
decreased circulating glucose level J:168271
decreased liver weight J:168271
improved glucose tolerance J:168271
Ay/a
Tyrp1B-lt/?

(Not Specified)
yellow coat color J:13094
Ay/A
(involves: C57BL/6)
hypoactivity J:131039
increased body length J:131039
increased brown adipose tissue amount J:131039
increased circulating leptin level J:131039
increased food intake J:131039
increased gonadal fat pad weight J:131039
increased inguinal fat pad weight J:131039
increased liver weight J:131039
increased percent body fat J:131039
increased retroperitoneal fat pad weight J:131039
increased susceptibility to weight gain J:131039
obese J:131039
yellow coat color J:131039
Ay/A
(C3HeB/FeJ)
yellow coat color J:30778
Ay/A
Pepddal/Pepddal

(involves: C3H/HeJ * CBA/J)
darkened coat color J:143333
obese J:143333
Ay/A
Prkar2btm2Gsm/Prkar2b+

(involves: C57BL/6)
increased percent body fat J:131039
increased susceptibility to weight gain J:131039
polyphagia J:131039
Ay/A
Prkar2btm2Gsm/Prkar2btm2Gsm

(involves: C57BL/6)
behavior/neurological phenotype J:131039
growth/size/body phenotype J:131039
hyperactivity J:131039
increased brown adipose tissue amount J:131039
increased gonadal fat pad weight J:131039
increased inguinal fat pad weight J:131039
increased percent body fat J:131039
increased retroperitoneal fat pad weight J:131039
increased susceptibility to weight gain J:131039
yellow coat color J:131039
Ay/Aw
(129S1.C3-Ay/Aw Chr 19MOLF/Ei)
decreased incidence of induced tumors J:146879
increased body weight J:146879
Ay/Ay
(101-Ay)
complete embryonic lethality at implantation J:174504
embryonic lethality J:174504
maternal effect J:174504
Aaastm1Ahue/Aaastm1Ahue
(involves: 129P2/OlaHsd * C57BL/6)
abnormal motor coordination/ balance J:106908
cellular phenotype J:106908
decreased body weight J:106908
decreased exploration in new environment J:106908
digestive/alimentary phenotype J:106908
endocrine/exocrine gland phenotype J:106908
female infertility J:106908
homeostasis/metabolism phenotype J:106908
hypoactivity J:106908
nervous system phenotype J:106908
AabprNZB/Slc/?
(involves: NZB/Slc * NZW/Slc)
increased B cell proliferation J:87690
Aadattm1Tag/Aadattm1Tag
(either: (involves: 129S/SvEv) or (involves: 129S/SvEv * Black Swiss))
abnormal neuron morphology J:92240
altered righting response J:92240
early eyelid opening J:92240
hyperactivity J:92240
impaired balance J:92240
Aaj1A/J/?
(involves: C57BL/6J * C57BL/6J-Chr1A/J)
increased anxiety-related response J:96389
Aaj2A/J/Aaj2A/J
(involves: C57BL/6J * C57BL/6J-Chr6A/J)
increased anxiety-related response J:96389
Aaj3A/J/Aaj3A/J
(involves: C57BL/6J * C57BL/6J-Chr6A/J)
increased anxiety-related response J:96389
Aaj4A/J/?
(involves: C57BL/6J * C57BL/6J-Chr17A/J)
increased anxiety-related response J:96389
Aal/?
(multiple strains)
abnormal active avoidance behavior J:8831, J:5380
AanatC57BL/6J/AanatC57BL/6J
(C57BL/6J)
abnormal pineal gland melatonin secretion J:27126
abnormal pineal gland physiology J:27126
Aaom1MRL/MpJ/Aaom1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
vasculitis J:83832
Aap/?
(DBA/2J)
abnormal active avoidance behavior J:5554
Aap/?
(C57BL/6J)
abnormal active avoidance behavior J:5554
Aaq1C57BL/6J/Aaq1C57BL/6J
(involves: C57BL/6J * DBA/2J)
abnormal alcohol consumption J:43654
Aaq1C57BL/6J/Aaq1DBA/2J
(involves: C57BL/6J * DBA/2J)
abnormal alcohol consumption J:43654
Aarssti/Aarssti
(B6.Cg-Aarssti)
abnormal hair shaft morphology J:110647
ataxia J:110647
disheveled coat J:110647
focal hair loss J:110647
hair follicle degeneration J:110647
hair follicle outer rooth sheath hyperplasia J:110647
impaired balance J:110647
Purkinje cell degeneration J:110647
tremors J:110647
AatfGt(pGT1.8geo)3Pgr/AatfGt(pGT1.8geo)3Pgr
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * NMRI))
abnormal cell morphology J:65741
abnormal preimplantation embryo development J:65741
complete embryonic lethality before implantation J:65741
decreased cell proliferation J:65741
decreased embryo size J:65741
embryonic growth arrest J:65741
failure of blastocyst formation J:65741
failure of morula compaction J:65741
failure to form blastocele J:65741
Aatktm1Shhi/Aatktm1Shhi
(involves: C57BL/6J)
abnormal axon morphology J:184851
abnormal axonal transport J:184851
abnormal neurite morphology J:184851
decreased brain size J:184851
Abbp1A/J/Abbp1C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp1C57BL/6/Abbp1C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp2C57BL/6/Abbp2C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp3A/J/Abbp3C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp3C57BL/6/Abbp3C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abbp4C57BL/6/Abbp4C57BL/6
(involves: A/J * C57BL/6)
increased systemic arterial blood pressure J:86889
Abca1m4620Dajl/Abca1+
(involves: C3H/HeSnJ * C57BL/6J * SWR)
decreased circulating cholesterol level J:149088
decreased circulating HDL cholesterol level J:149088
Abca1m4620Dajl/Abca1m4620Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
decreased circulating cholesterol level J:149088
decreased circulating HDL cholesterol level J:149088
increased circulating triglyceride level J:149088
Abca1tm1.1Jp/Abca1tm1.1Jp
(involves: 129S6/SvEvTac * C57BL/6)
abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
Abca1tm1Blt/Abca1tm1Blt
(C57BL/6-Abca1tm1Blt)
abnormal platelet physiology J:95088
Abca1tm1Jdm/Abca1+
(DBA/1LacJ-Abca1tm1Jdm)
abnormal circulating phospholipid level J:61679
abnormal lipid homeostasis J:61679
abnormal lung morphology J:61679
decreased circulating cholesterol level J:61679
decreased circulating HDL cholesterol level J:61679
decreased circulating LDL cholesterol level J:61679
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm)
abnormal circulating phospholipid level J:61679
abnormal fat-soluble vitamin level J:60210
abnormal lipid homeostasis J:61679
abnormal lung morphology J:61679
abnormal placenta development J:63265
abnormal pulmonary alveolus morphology J:61679
decreased body weight J:60210
decreased circulating cholesterol level J:60210, J:61679
decreased circulating HDL cholesterol level J:60210, J:61679
decreased circulating LDL cholesterol level J:61679
decreased platelet cell number J:60210
enlarged adrenal glands J:60210
enlarged spleen J:60210
female infertility J:63265
hemorrhage J:63265
impaired macrophage phagocytosis J:63265
increased intestinal cholesterol absorption J:61679
partial perinatal lethality J:61679
partial postnatal lethality J:63265
Abca1tm1Jdm/Abca1tm1Jdm
(involves: DBA/1LacJ)
abnormal circulating plant sterol level J:87209
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1-Abca1tm1Jdm/J)
increased cholesterol efflux J:130777
Abca1tm1Jdm/Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ)
abnormal thymus morphology J:132254
decreased circulating cholesterol level J:132254
decreased circulating HDL cholesterol level J:132254
homeostasis/metabolism phenotype J:132254
impaired macrophage phagocytosis J:132254
partial perinatal lethality J:132254
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen

(involves: 129P2/OlaHsd * C57BL/6 * DBA/1LacJ)
abnormal chemokine secretion J:130777
abnormal cytokine secretion J:130777
decreased cholesterol efflux J:130777
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen

(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
abnormal bone marrow cell morphology/development J:190966
abnormal bone structure J:190966
abnormal common myeloid progenitor cell morphology J:190966
abnormal hematopoietic system physiology J:190966
decreased monocyte cell number J:190966
extramedullary hematopoiesis J:190966
increased hematopoietic stem cell number J:190966
increased monocyte cell number J:190966
increased neutrophil cell number J:190966
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen
Apoetm1Unc/Apoetm1Unc

(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
abnormal hematopoietic system physiology J:190966
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen
Tg(APOA1)1Rub/0

(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
abnormal hematopoietic system physiology J:190966
Abca1tm1Jdm/Abca1tm1Jdm
Tg(Thy1-APP)3Somm/0

(involves: C57BL/6J * DBA/1LacJ * DBA/2)
amyloidosis J:105902
cerebral amyloid angiopathy J:105902
intracerebral hemorrhage J:105902
partial preweaning lethality J:105902
Abca1tm1Jdm/Abca1tm1Jdm
Tgm2tm1Gml/Tgm2tm1Gml

(involves: C57BL/6 * DBA/1LacJ)
abnormal thymus morphology J:132254
decreased circulating cholesterol level J:132254
decreased circulating HDL cholesterol level J:132254
homeostasis/metabolism phenotype J:132254
impaired macrophage phagocytosis J:132254
perinatal lethality J:132254
Abca1tm1Jp/Abca1+
Tg(Alb-cre)21Mgn/0

(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
abnormal cholesterol homeostasis J:98093
abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
Abca1tm1Jp/Abca1+
Tg(Vil-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * SJL)
decreased circulating cholesterol level J:107802
decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Abcg1tm1Tall/Abcg1tm1Tall
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
abnormal bone marrow cell morphology/development J:190966
increased interleukin-17 secretion J:190966
increased interleukin-23 secretion J:190966
Abca1tm1Jp/Abca1tm1Jp
Abcg1tm1Tall/Abcg1tm1Tall
Tg(Itgax-cre,-EGFP)4097Ach/0

(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
abnormal bone marrow cell morphology/development J:190966
increased interleukin-17 secretion J:190966
increased interleukin-23 secretion J:190966
Abca1tm1Jp/Abca1tm1Jp
Tg(Alb-cre)21Mgn/0

(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
abnormal cholesterol homeostasis J:98093
abnormal circulating phospholipid level J:98093
decreased circulating cholesterol level J:98093
decreased circulating HDL cholesterol level J:98093
decreased circulating LDL cholesterol level J:98093
increased circulating triglyceride level J:98093
Abca1tm1Jp/Abca1tm1Jp
Tg(Alb-cre)21Mgn/0

(involves: 129S6/SvEvTac * C57BL/6 * DBA)
decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Tg(Alb-cre)21Mgn/0
Tg(Vil-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * DBA * SJL)
decreased circulating HDL cholesterol level J:107802
Abca1tm1Jp/Abca1tm1Jp
Tg(Vil-cre)997Gum/0

(involves: 129S6/SvEvTac * C57BL/6 * SJL)
abnormal enterocyte physiology J:107802
decreased cholesterol efflux J:107802
decreased circulating cholesterol level J:107802
decreased circulating HDL cholesterol level J:107802
decreased circulating LDL cholesterol level J:107802
Abca1tm1Wpfl/Abca1+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal placenta labyrinth morphology J:64390
cardiomyopathy J:64390
decreased circulating cholesterol level J:64390
decreased circulating HDL cholesterol level J:64390
heart left ventricle hypertrophy J:64390
heart right ventricle hypertrophy J:64390
lung hemorrhage J:64390
reduced female fertility J:64390
respiratory distress J:64390
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal adrenal gland morphology J:64390
abnormal kidney cortex morphology J:64390
abnormal ovary morphology J:64390
abnormal placenta labyrinth morphology J:64390
abnormal Sertoli cell morphology J:64390
abnormal thymus morphology J:64390
abnormal uterus morphology J:64390
cardiomyopathy J:64390
decreased body size J:64390
decreased circulating cholesterol level J:68431, J:64390
decreased circulating estradiol level J:64390
decreased circulating HDL cholesterol level J:68431, J:64390
decreased circulating progesterone level J:64390
decreased intestinal cholesterol absorption J:68431
embryonic growth arrest J:64390
embryonic growth retardation J:64390
glomerulonephritis J:64390
glomerulosclerosis J:64390
heart left ventricle hypertrophy J:64390
heart right ventricle hypertrophy J:64390
hepatic steatosis J:64390
lung hemorrhage J:64390
partial lethality throughout fetal growth and development J:64390
partial postnatal lethality J:64390
reduced female fertility J:64390
respiratory distress J:64390
uterus inflammation J:64390
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129 * C57BL/6)
abnormal Sertoli cell morphology J:101966
Abca1tm1Wpfl/Abca1tm1Wpfl
Npc1m1N/Npc1m1N

(involves: 129P2/OlaHsd * BALB/c)
decreased brain cholesterol level J:130969
increased cholesterol level J:130969
premature death J:130969
Abca1tm2Jp/Abca1+
Tg(APOA1)427Bres/?

(involves: 129X1/SvJ * C57BL/6J * CBA/J)
abnormal circulating cholesterol level J:104719
abnormal circulating protein level J:104719
decreased circulating HDL cholesterol level J:104719
decreased circulating phospholipid level J:104719
Abca1tm2Jp/Abca1tm2Jp
Tg(APOA1)427Bres/?

(involves: 129X1/SvJ * C57BL/6J * CBA/J)
abnormal circulating cholesterol level J:104719
abnormal circulating protein level J:104719
abnormal kidney physiology J:104719
decreased circulating HDL cholesterol level J:104719
decreased circulating phospholipid level J:104719
Abca2tm1Kdt/Abca2tm1Kdt
(involves: 129/Sv)
abnormal motor coordination/ balance J:117673
abnormal myelin sheath morphology J:117673
decreased body weight J:117673
enhanced coordination J:117673
hyperactivity J:117673
increased fear-related response J:117673
increased startle reflex J:117673
increased vertical activity J:117673
tremors J:117673
Abca2tm1Nina/Abca2tm1Nina
(involves: 129X1/SvJ * C57BL/6)
abnormal emotion/affect behavior J:123521
abnormal lipid level J:123521
decreased body weight J:123521
impaired balance J:123521
increased sensitivity to induced morbidity/mortality J:123521
reduced female fertility J:123521
tremors J:123521
Abca3tm1Dgen/Abca3+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal lung development J:124809
abnormal surfactant physiology J:124809
decreased alveolar lamellar body number J:124809
Abca3tm1Dgen/Abca3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal pulmonary alveolus morphology J:124809
abnormal surfactant secretion J:124809
absent alveolar lamellar bodies J:124809
complete neonatal lethality J:124809
partial prenatal lethality J:124809
thick pulmonary interalveolar septum J:124809
Abca3tm1Frm/Abca3tm1Frm
(involves: 129S/SvEv)
abnormal lipid homeostasis J:120296
abnormal surfactant secretion J:120296
absent alveolar lamellar bodies J:120296
complete neonatal lethality J:120296
cyanosis J:120296
lethargy J:120296
primary atelectasis J:120296
pulmonary alveolar hemorrhage J:120296
renal/urinary system phenotype J:120296
respiratory failure J:120296
Abca3tm1Holz/Abca3tm1Holz
(involves: 129S6/SvEvTac * C57BL/6)
abnormal alveolar lamellar body morphology J:122736
abnormal surfactant physiology J:122736
abnormal type II pneumocyte morphology J:122736
atelectasis J:122736
complete neonatal lethality J:122736
cyanosis J:122736
lethargy J:122736
respiratory distress J:122736
respiratory failure J:122736
Abca3tm1Nina/Abca3tm1Nina
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal alveolar lamellar body morphology J:121155
abnormal bronchiole epithelium morphology J:121155
abnormal lung development J:121155
abnormal lung saccule morphology J:121155
abnormal surfactant composition J:121155
abnormal type II pneumocyte morphology J:121155
absent alveolar lamellar bodies J:121155
absent type I pneumocytes J:121155
atelectasis J:121155
complete neonatal lethality J:121155
cyanosis J:121155
increased wet-to-dry lung weight ratio J:121155
pulmonary vascular congestion J:121155
respiratory failure J:121155
thick lung-associated mesenchyme J:121155
Abca4tm1a(EUCOMM)Wtsi/?
(Not Specified)
abnormal epidermal pigmentation J:175295
abnormal epidermis stratum basale morphology J:175295
Abca4tm1a(EUCOMM)Wtsi/Abca4+
(Not Specified)
abnormal respiratory quotient J:175295
increased respiratory quotient J:175295
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae * C57BL/6)
abnormal Bruch membrane morphology J:56317
abnormal eye physiology J:56317
abnormal photoreceptor outer segment morphology J:56317
abnormal retinal pigment epithelium morphology J:56317
delayed dark adaptation J:56317
retinal photoreceptor degeneration J:56317
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae)
abnormal eye physiology J:117483
abnormal retinal pigment epithelium morphology J:141801
abnormal vitamin A level J:141801
Abca4tm1Ght/Abca4tm1Ght
(involves: 129S4/SvJae * BALB/c)
abnormal retinal pigment epithelium morphology J:141801
photoreceptor outer segment degeneration J:141801
thin retinal outer nuclear layer J:141801
Abca4tm1Ght/Abca4tm1Ght
Rdh8tm1Kpal/Rdh8tm1Kpal

(involves: 129S4/SvJae)
abnormal Bruch membrane morphology J:154536
abnormal cone electrophysiology J:154536
abnormal eye electrophysiology J:154536
abnormal retinal photoreceptor morphology J:154536
abnormal retinal pigment epithelium morphology J:154536
abnormal retinal pigmentation J:154536
abnormal rod electrophysiology J:154536
decreased retinal cone cell number J:154536
decreased retinal photoreceptor cell number J:154536
retinal degeneration J:154536
retinal deposits J:154536
retinal neovascularization J:154536
thin retinal outer nuclear layer J:154536
Abca4tm1Kpal/Abca4tm1Kpal
(involves: 129S/SvEv * C57BL/6)
no phenotypic analysis J:135257
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
abnormal liver physiology J:99152
abnormal thyroid follicle morphology J:99152
absent thyroid gland J:99152
decreased activity of thyroid J:99152
dilated cardiomyopathy J:99152
exophthalmos J:99152
myocardial fiber degeneration J:99152
thrombosis J:99152
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
abnormal liver morphology J:99152
abnormal thyroid follicle morphology J:99152
absent thyroid gland J:99152
decreased activity of thyroid J:99152
dilated cardiomyopathy J:99152
edema J:99152
exophthalmos J:99152
myocardial fiber degeneration J:99152
premature death J:99152
thrombosis J:99152
tremors J:99152
visceral vascular congestion J:99152
Abca7tm1Frm/Abca7tm1Frm
(involves: 129S4/SvJae * C57BL/6)
decreased circulating cholesterol level J:96865
decreased circulating HDL cholesterol level J:96865
decreased white adipose tissue amount J:96865
small kidney J:96865
Abca12el12/Abca12+
(involves: 129/Sv * C57BL/6)
abnormal lipid homeostasis J:161652
decreased cholesterol efflux J:161652
Abca12el12/Abca12el12
(involves: 129/Sv * C57BL/6)
abnormal corneocyte envelope morphology J:161652
abnormal epidermal lamellar body morphology J:161652
abnormal epidermis stratum basale morphology J:161652
abnormal lipid homeostasis J:161652
abnormal skin development J:161652
abnormal skin morphology J:161652
complete neonatal lethality J:161652
decreased cholesterol efflux J:161652
decreased fetal size J:161652
dehydration J:161652
hyperkeratosis J:161652
impaired skin barrier function J:161652
increased cholesterol level J:161652
no suckling reflex J:161652
thick epidermis stratum granulosum J:161652
thin epidermis J:161652
thin epidermis stratum spinosum J:161652
tight skin J:161652
Abca12tm1Lex/Abca12tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
complete preweaning lethality J:103485
Abca12tm1Lex/Abca12tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
abnormal epidermal lamellar body morphology J:144062
abnormal lipid homeostasis J:144062
complete neonatal lethality J:144062
epidermal desquamation J:144062
hyperkeratosis J:144062
impaired skin barrier function J:144062
parakeratosis J:144062
Abca12tm1Shzu/Abca12tm1Shzu
(B6.129S-Abca12tm1Shzu)
abnormal epidermal lamellar body morphology J:139048
abnormal epidermal layer morphology J:139048
abnormal pulmonary alveolus morphology J:139048
abnormal skin condition J:139048
abnormal skin development J:139048
abnormal surfactant secretion J:139048
abnormal type II pneumocyte morphology J:139048
absent alveolar lamellar bodies J:139048
atelectasis J:139048
complete neonatal lethality J:139048
decreased birth weight J:139048
decreased fetal weight J:139048
dehydration J:139048
everted lip J:139048
hyperkeratosis J:139048
impaired skin barrier function J:139048
pulmonary vascular congestion J:139048
reddish skin J:139048
scaly skin J:139048
shiny skin J:139048
skin lesions J:139048
thick pulmonary interalveolar septum J:139048
tight skin J:139048
Abcb1amds/Abcb1amds
(involves: CF-1)
abnormal hippocampus CA3 region morphology J:64725
catalepsy J:64725
hippocampal neuron degeneration J:64725
increased eosinophil cell number J:64725
increased physiological sensitivity to xenobiotic J:40292, J:64725
premature death J:64725
tremors J:64725
Abcb1atm1.1Kane/Abcb1a+
(involves: 129S1/SvImJ)
no phenotypic analysis J:147139
Abcb1atm1Bor/Abcb1atm1Bor
(involves: 129P2/OlaHsd * FVB)
abnormal blood-brain barrier function J:18554
abnormal xenobiotic pharmacokinetics J:39804
increased physiological sensitivity to xenobiotic J:18554
Abcb1atm1Bor/Abcb1atm1Bor
(FVBTac.129P2-Abcb1atm1Bor)
abnormal blood-inner ear barrier function J:59145
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology J:102640
abnormal xenobiotic pharmacokinetics J:59145, J:102640
decreased gamma-delta intraepithelial T cell number J:102640
increased physiological sensitivity to xenobiotic J:59145
increased susceptibility to ototoxicity-induced hearing loss J:59145
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor

(involves: 129P2/OlaHsd * FVB)
abnormal xenobiotic pharmacokinetics J:39804
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor

(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor)
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology J:102640
abnormal T cell physiology J:102640
abnormal xenobiotic pharmacokinetics J:102640, J:107822
decreased gamma-delta intraepithelial T cell number J:102640
increased double-positive T cell number J:102640
increased interferon-gamma secretion J:102640
increased interleukin-2 secretion J:102640
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
Abcc2tm1Ahs/Abcc2tm1Ahs

(FVB.129P2-Abcb1btm1Bor Abcb1atm1Bor Abcc2tm1Ahs)
abnormal xenobiotic pharmacokinetics J:107822
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
Tg(Thy1-AppDutch)#Jckr/0

(FVB.Cg-Abcb1btm1Bor Abcb1atm1Bor Tg(Thy1-AppDutch)#Jckr)
amyloid beta deposits J:178230
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0

(FVB.Cg-Abcb1btm1Bor Abcb1atm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
amyloid beta deposits J:178230
Abcb1atm1Bor/Abcb1atm1Bor
Npc1m1N/Npc1m1N

(involves: 129/Ola * BALB/c)
abnormal maternal nurturing J:76395
abnormal motor capabilities/coordination/movement J:76395
increased liver cholesterol level J:76395
reproductive system phenotype J:76395
Abcb1atm1Kane/Abcb1a+
(involves: 129S1/SvImJ)
no phenotypic analysis J:147139
Abcb1btm2Bor/Abcb1btm2Bor
(involves: 129P2/OlaHsd * FVB)
abnormal xenobiotic pharmacokinetics J:39804
Abcb4tm1Bor/Abcb4tm1Bor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))
abnormal bile canaliculus morphology J:21232, J:15531
abnormal bile composition J:15531
abnormal bile duct morphology J:15531
abnormal bile secretion J:15531
abnormal blood homeostasis J:15531
abnormal circulating alanine transaminase level J:15531
abnormal circulating alkaline phosphatase level J:15531
abnormal circulating aspartate transaminase level J:15531
abnormal circulating bilirubin level J:15531
abnormal hepatobiliary system morphology J:21232
abnormal hepatobiliary system physiology J:21232
abnormal hepatocyte morphology J:15531
abnormal portal triad morphology J:21232
bile duct inflammation J:21232, J:15531
bile duct proliferation J:21232
biliary cirrhosis J:21232
cholestasis J:21232
dilated bile duct J:15531
enlarged liver J:21232
hepatic necrosis J:21232
increased hepatocellular carcinoma incidence J:21232
intrahepatic cholestasis J:15531
liver hemorrhage J:21232
liver inflammation J:15531
reduced female fertility J:21232
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB)
abnormal circulating enzyme level J:114411
abnormal lipid homeostasis J:114411
decreased circulating cholesterol level J:114411
decreased intestinal cholesterol absorption J:114411
increased circulating alanine transaminase level J:114411
increased circulating aspartate transaminase level J:114411
increased circulating bilirubin level J:114411
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
abnormal bile composition J:100491
abnormal feces composition J:100491
homeostasis/metabolism phenotype J:100491
increased circulating alanine transaminase level J:100491
increased circulating aspartate transaminase level J:100491
Abcb4tm1Bor/Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor)
abnormal bone remodeling J:199949
abnormal compact bone morphology J:199949
abnormal enzyme/coenzyme activity J:199949
abnormal trabecular bone morphology J:199949
abnormal trabecular bone volume J:199949
decreased bone mineral content J:199949
decreased bone mineral density J:199949
decreased bone trabecula number J:199949
decreased bone volume J:199949
decreased circulating calcium level J:199949
decreased trabecular bone connectivity density J:199949
decreased vitamin D level J:199949
increased alkaline phosphatase activity J:199949
increased circulating phosphate level J:199949
increased transforming growth factor level J:199949
liver fibrosis J:199949
Abcb4tm1Bor/Abcb4tm1Bor
Tg(ABCG5/ABCG8)14-2Hobb/0

(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
abnormal bile composition J:100491
abnormal feces composition J:100491
decreased intestinal cholesterol absorption J:100491
homeostasis/metabolism phenotype J:100491
increased circulating alanine transaminase level J:100491
increased circulating aspartate transaminase level J:100491
Abcb6tm1a(KOMP)Wtsi/?
(Not Specified)
increased chromosomal stability J:175295
Abcb6tm1Jsch/Abcb6tm1Jsch
(involves: 129)
abnormal erythrocyte physiology J:184574
abnormal erythropoiesis J:184574
abnormal mitochondrial physiology J:184574
increased physiological sensitivity to xenobiotic J:184574
increased sensitivity to xenobiotic induced morbidity/mortality J:184574
partial lethality J:184574
Abcb6tm1Pkr/Abcb6tm1Pkr
(involves: C57BL/6)
decreased physiological sensitivity to xenobiotic J:190243
Abcb7tm1.1Mdf/Y
(involves: 129S4/SvJae * FVB)
prenatal lethality J:106838
Abcb7tm1.1Mdf/Abcb7+
(involves: 129S4/SvJae * FVB)
genetic imprinting J:106838
prenatal lethality J:106838
Abcb7tm1Mdf/Y
Tg(Alb-cre)21Mgn/0

(either: B6.Cg-Abcb7tm1Mdf Tg(Alb-cre)21Mgn or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA))
abnormal circulating enzyme level J:106838
abnormal enzyme/coenzyme activity J:106838
abnormal hepatocyte morphology J:106838
abnormal liver morphology J:106838
hemosiderosis J:106838
Abcb7tm1Mdf/Y
Tg(Gata1-cre)1Sho/0

(either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB) or (involves: 129S4/SvJae * C57BL/6J * FVB))
abnormal ectoplacental cone morphology J:106838
complete embryonic lethality between implantation and somite formation J:106838
embryonic growth retardation J:106838
hemorrhage J:106838
Abcb7tm1Mdf/Y
Tg(Nes-cre)1Kln/0

(either: B6.Cg-Tg(Nes-cre)1Kln Abcb7tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL))
complete postnatal lethality J:106838
nervous system phenotype J:106838
partial neonatal lethality J:106838
Abcb7tm1Mdf/Y
Tg(Sox2-cre)1Amc/0

(either: B6.Cg-Abcb7tm1Mdf Tg(Sox2-cre)1Amc or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA))
complete embryonic lethality between somite formation and embryo turning J:106838
Abcb7tm1Mdf/Y
Tg(Vil-cre)20Syr/0

(either: (involves: 129S4/SvJae * C57BL/6 * DBA/2) or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2))
complete prenatal lethality J:106838
Abcb7tm1Mdf/Abcb7+
Tg(Gata1-cre)1Sho/0

(either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB) or (involves: 129S4/SvJae * C57BL/6J * FVB))
abnormal ectoplacental cone morphology J:106838
complete embryonic lethality between implantation and somite formation J:106838
embryonic growth retardation J:106838
hemorrhage J:106838
Abcb7tm1Mdf/Abcb7+
Tg(Sox2-cre)1Amc/0

(either: B6.Cg-Abcb7tm1Mdf Tg(Sox2-cre)1Amc or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA))
mortality/aging J:106838
Abcb7tm1Mdf/Abcb7+
Tg(Vil-cre)20Syr/0

(either: (involves: 129S4/SvJae * C57BL/6 * DBA/2) or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2))
complete prenatal lethality J:106838
Abcb8tm1Hard/Abcb8tm1Hard
Tg(Myh6-cre/Esr1*)1Jmk/0

(involves: FVB)
abnormal cardiac muscle relaxation J:182234
abnormal cardiovascular system physiology J:182234
abnormal heart iron level J:182234
abnormal heart morphology J:182234
abnormal myocardial fiber morphology J:182234
cardiac fibrosis J:182234
cardiomyopathy J:182234
decreased cardiac muscle contractility J:182234
decreased cardiac output J:182234
decreased left ventricle systolic pressure J:182234
increased heart left ventricle size J:182234
increased heart weight J:182234
Abcb10tm1Lex/Abcb10+
(involves: 129S/SvEvBrd * C57BL/6)
abnormal mitochondrial physiology J:189396
cardiovascular system phenotype J:189396
decreased systemic arterial systolic blood pressure J:189396
increased response of heart to induced stress J:189396
increased systemic arterial diastolic blood pressure J:189396
oxidative stress J:189396
Abcb10tm1Lex/Abcb10tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
complete embryonic lethality J:189396
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal bile canaliculus morphology J:67548
abnormal bile salt level J:67548
abnormal bile secretion J:67548
abnormal hepatocyte morphology J:67548
abnormal phospholipid level J:67548
decreased body weight J:67548
decreased glycogen level J:67548
enlarged liver J:67548
increased bile salt level J:67548
increased cholesterol level J:67548
intrahepatic cholestasis J:67548
postnatal growth retardation J:67548
Abcc1tm1Acs/Abcc1tm1Acs
(involves: 129S1/Sv * C57BL/6)
abnormal homeostasis J:44305
hematopoietic system phenotype J:44305
increased physiological sensitivity to xenobiotic J:44305
Abcc1tm1Bor/Abcc1tm1Bor
(involves: 129P2/OlaHsd * FVB)
abnormal mast cell physiology J:44110
decreased inflammatory response J:44110
increased physiological sensitivity to xenobiotic J:44110
increased sensitivity to xenobiotic induced morbidity/mortality J:44110
mortality/aging J:44110
Abcc1tm1Bor/Abcc1tm1Bor
Tg(Thy1-AppDutch)#Jckr/0

(FVB.Cg-Abcc1tm1Bor Tg(Thy1-AppDutch)#Jckr)
abnormal homeostasis J:178230
amyloid beta deposits J:178230
Abcc1tm1Bor/Abcc1tm1Bor
Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0

(FVB.Cg-Abcc1tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
amyloid beta deposits J:178230
microgliosis J:178230
Abcc2tm1Ahs/Abcc2tm1Ahs
(involves: 129P2/OlaHsd * FVB)
abnormal bile secretion J:107822
abnormal blood homeostasis J:107822
abnormal kidney physiology J:107822
abnormal liver physiology J:107822
abnormal xenobiotic pharmacokinetics J:107822
bilirubinuria J:107822
decreased hemoglobin content J:107822
increased circulating bilirubin level J:107822
increased liver weight J:107822
Abcc2tm1Ahs/Abcc2tm1Ahs
(FVB.129P2-Abcc2tm1Ahs)
abnormal xenobiotic pharmacokinetics J:107822
Abcc2tm1Dgen/Abcc2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal bile composition J:134950
abnormal bile secretion J:134950
abnormal liver physiology J:134950
decreased circulating alkaline phosphatase level J:134950
increased circulating bilirubin level J:134950
increased circulating cholesterol level J:134950
Abcc3tm1Bor/Abcc3tm1Bor
(involves: 129P2/Ola * FVB)
abnormal bile salt homeostasis J:149653
abnormal xenobiotic pharmacokinetics J:99234
Abcc3tm1Bor/Abcc3tm1Bor
(FVB.129P2-Abcc3tm1Bor)
abnormal xenobiotic pharmacokinetics J:99234
decreased chemically-elicited antinociception J:99234
Abcc3tm1Kruh/Abcc3tm1Kruh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal bile salt level J:114229
increased circulating bilirubin level J:114229
liver/biliary system phenotype J:114229
Abcc3tm1Kruh/Abcc3tm1Kruh
Slc51atm1Pda/Slc51atm1Pda

(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
abnormal bile salt homeostasis J:132778
Abcc4Gt(pU21)93Imeg/?
(involves: C57BL/6 * CBA)
no phenotypic analysis J:109358
Abcc4Gt(RRC212)Byg/Abcc4Gt(RRC212)Byg
(involves: 129P2/OlaHsd * C57BL/6)
decreased prostaglandin level J:139829
increased chemical nociceptive threshold J:139829
increased thermal nociceptive threshold J:139829
Abcc4tm1Jsch/Abcc4tm1Jsch
(involves: 129X1/SvJ)
abnormal blood-brain barrier function J:92788
abnormal blood-cerebrospinal fluid barrier function J:92788
abnormal urine organic anion level J:92788
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
abnormal blood homeostasis J:117326
abnormal blood-brain barrier function J:117326
abnormal intestinal mucosa morphology J:117326
abnormal small intestine morphology J:117326
abnormal spleen B cell follicle morphology J:117326
abnormal spleen red pulp morphology J:117326
increased sensitivity to induced morbidity/mortality J:117326
increased susceptibility to induced colitis J:117326
intestinal inflammation J:117326
small intestinal inflammation J:117326
small spleen J:117326
thymus cortex hypoplasia J:117326
weight loss J:117326
Abcc5tm1Bor/Abcc5tm1Bor
(involves: 129P2/OlaHsd * FVB)
cellular phenotype J:135561
Abcc6Dyscalc1-C3H/DiSnA/Abcc6Dyscalc1-C57BL/10
(involves: C3H/DiSnA * C57BL/10)
decreased susceptibility to dystrophic cardiac calcinosis J:76777
Abcc6Dyscalc1-C3H/HeJ/Abcc6Dyscalc1-C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
increased susceptibility to dystrophic cardiac calcinosis J:72021, J:33253
Abcc6Dyscalc1-C3H/HeJ/Abcc6Dyscalc1-C3H/HeJ
Dyscalc2C3H/HeJ/?

(involves: C3H/HeJ * C57BL/6J)
increased susceptibility to dystrophic cardiac calcinosis J:72021
Abcc6Dyscalc1-C3H/HeJ/Abcc6Dyscalc1-C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
decreased susceptibility to dystrophic cardiac calcinosis J:72021
Abcc6Dyscalc1-C3H/HeNCrl/Abcc6Dyscalc1-C3H/HeNCrl
(involves: C3H/HeNCrl * C57BL/6NCrl)
increased susceptibility to dystrophic cardiac calcinosis J:109580
Abcc6Dyscalc1-C57BL/6J/Abcc6Dyscalc1-C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
decreased susceptibility to dystrophic cardiac calcinosis J:72021
Abcc6Dyscalc1-C57BL/10/Abcc6Dyscalc1-C57BL/10
(involves: C3H/DiSnA * C57BL/10)
decreased susceptibility to dystrophic cardiac calcinosis J:76777
Abcc6Dyscalc1-DBA/2J/Abcc6Dyscalc1-DBA/2J
(involves: C57BL/6J * DBA/2J)
increased susceptibility to dystrophic cardiac calcinosis J:76777
Abcc6tm1Aabb/Abcc6tm1Aabb
(involves: 129P2/OlaHsd * C57BL/6)
abnormal Bruch membrane morphology J:105062
abnormal kidney blood vessel morphology J:105062
calcified artery J:105062
calcified skin J:105062
decreased circulating HDL cholesterol level J:105062
increased circulating creatinine level J:105062
Abcc6tm1Jfk/Abcc6tm1Jfk
(involves: 129S1/Sv * C57BL/6J)
abnormal vibrissa follicle morphology J:101372
calcified artery J:101372
calcified retina J:101372
calcified skin J:101372
calcinosis J:101372
nephrocalcinosis J:101372
Abcc8tm1.1Fmas/Abcc8+
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
abnormal pancreatic beta cell morphology J:208932
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
abnormal pancreatic beta cell morphology J:208932
decreased circulating glucose level J:208932
decreased insulin secretion J:208932
homeostasis/metabolism phenotype J:208932
impaired glucose tolerance J:208932
increased circulating glucose level J:208932
increased insulin secretion J:208932
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn
(involves: 129X1/SvJ * C57BL/6)
decreased insulin secretion J:79352
hypoglycemia J:79352
impaired glucose tolerance J:79352
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ * C57BL/6)
hypoglycemia J:61356
impaired glucose tolerance J:61356
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ)
abnormal insulin secretion J:179577
decreased circulating glucose level J:179577
decreased insulin secretion J:179577
increased circulating glucose level J:179577
Abcc8tm1Jbry/Abcc8tm1Jbry
Sstr5tm1Fcb/Sstr5tm1Fcb

(involves: 129X1/SvJ)
abnormal insulin secretion J:179577
decreased circulating glucose level J:179577
decreased insulin secretion J:179577
increased circulating glucose level J:179577
Abcc8tm1Mgn/Abcc8+
(involves: 129X1/SvJ)
no phenotypic analysis J:79352
Abcc9tm1Cfb/Abcc9tm1Cfb
(involves: CD-1)
abnormal muscle cell glucose uptake J:71840
hypoglycemia J:71840
improved glucose tolerance J:71840
increased insulin sensitivity J:71840
premature death J:71840
slow postnatal weight gain J:71840
Abcc9tm1Cfb/Abcc9tm1Cfb
(Not Specified)
abnormal ST segment J:78066
abnormal systemic arterial blood pressure J:78066
abnormal vascular smooth muscle physiology J:78066
abnormal vasoconstriction J:78066
artery stenosis J:78066
hypertension J:78066
increased systemic arterial diastolic blood pressure J:78066
increased systemic arterial systolic blood pressure J:78066
premature death J:78066
Abcc10tm1Eah/Abcc10tm1Eah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal spleen red pulp morphology J:172648
decreased body weight J:172648
decreased bone marrow cell number J:172648
decreased leukocyte cell number J:172648
decreased spleen germinal center number J:172648
decreased spleen germinal center size J:172648
decreased spleen white pulp amount J:172648
increased physiological sensitivity to xenobiotic J:172648
increased sensitivity to induced morbidity/mortality J:172648
small spleen J:172648
thymus cortex hypoplasia J:172648
Abcc12tm1Bor/Abcc12+
(Not Specified)
no phenotypic analysis J:125562
Abcd1tm1a(EUCOMM)Wtsi/Y
(Not Specified)
abnormal lens morphology J:165965
cataracts J:165965
Abcd1tm1a(EUCOMM)Wtsi/Abcd1tm1a(EUCOMM)Wtsi
(Not Specified)
abnormal lens morphology J:165965
cataracts J:165965
decreased mean corpuscular hemoglobin J:165965
increased hematocrit J:165965
other phenotype J:165965
Abcd1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal lipid homeostasis J:44812
reduced fertility J:44812
Abcd1tm1Kan/Abcd1tm1Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal lipid homeostasis J:44812
reduced fertility J:44812
Abcd1tm1Kds/Y
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
abnormal lipid homeostasis J:42479
increased saturated fatty acid level J:42479
Abcd1tm1Kds/Y
(involves: 129S4/SvJae * C57BL/6J)
abnormal adrenal cortex morphology J:94583
abnormal astrocyte morphology J:94583
abnormal locomotor activation J:94583
abnormal microglial cell morphology J:94583
abnormal myelination J:94583
abnormal nerve conduction J:94583
abnormal nervous system physiology J:94583
abnormal spinal cord morphology J:94583
abnormal zona fasciculata morphology J:94583
abnormal zona reticularis morphology J:94583
astrocytosis J:94583
axon degeneration J:94583
impaired coordination J:94583
increased fatty acid level J:94583
Abcd1tm1Kds/Y
Abcd2tm1Apuj/Abcd2tm1Apuj

(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
abnormal adrenal cortex morphology J:94583
abnormal astrocyte morphology J:94583
abnormal CNS glial cell morphology J:104122
abnormal involuntary movement J:104122
abnormal locomotor activation J:94583
abnormal locomotor behavior J:104122
abnormal microglial cell morphology J:94583
abnormal nerve conduction J:94583
abnormal nervous system electrophysiology J:104122
abnormal nervous system physiology J:94583
abnormal posture J:104122
astrocytosis J:94583
ataxia J:104122
axon degeneration J:94583
decreased vertical activity J:104122
impaired balance J:104122
impaired coordination J:94583
increased fatty acid level J:94583, J:104122
increased inflammatory response J:94583
tremors J:104122
Abcd1tm1Kds/Y
Slc27a2tm1Kds/Slc27a2tm1Kds

(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J)
no abnormal phenotype detected J:83438
Abcd1tm1Kds/Abcd1tm1Kds
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
abnormal lipid homeostasis J:42479
increased saturated fatty acid level J:42479
Abcd1tm1Kds/Abcd1tm1Kds
(involves: 129/Sv * 129S4/SvJae * C57BL/6J)
abnormal motor coordination/ balance J:75388
abnormal myelination J:75388
abnormal nerve conduction J:75388
abnormal Schwann cell morphology J:75388
axon degeneration J:75388
decreased vertical activity J:75388
impaired coordination J:75388
Abcd1tm1Kds/Abcd1tm1Kds
Slc27a2tm1Kds/Slc27a2tm1Kds

(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J)
no abnormal phenotype detected J:83438
Abcd1tm1Ymd/Y
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
abnormal lipid homeostasis J:40230
Abcd1tm1Ymd/Abcd1tm1Ymd
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
abnormal lipid homeostasis J:40230
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal astrocyte morphology J:94583
abnormal axon morphology J:104122
abnormal cerebellar Purkinje cell layer J:104122
abnormal CNS glial cell morphology J:104122
abnormal dorsal root ganglion morphology J:104122
abnormal locomotor behavior J:104122
abnormal microglial cell morphology J:94583
abnormal motor coordination/ balance J:104122
abnormal nervous system electrophysiology J:104122
abnormal nervous system physiology J:104122
abnormal posture J:104122
abnormal Purkinje cell morphology J:104122
astrocytosis J:104122
ataxia J:104122
axon degeneration J:94583, J:104122
gliosis J:104122
hyperactivity J:104122
impaired balance J:104122
impaired coordination J:104122
increased fatty acid level J:94583, J:104122
neuron degeneration J:104122
Purkinje cell degeneration J:104122
tremors J:104122
Abcd4tm1a(EUCOMM)Hmgu/Abcd4tm1a(EUCOMM)Hmgu
(Not Specified)
abnormal response to new environment J:165965
abnormal response to tactile stimuli J:165965
abnormal startle reflex J:165965
other phenotype J:165965
Abce1Tg(Tyr)2295G-2b3Ove/Abce1Tg(Tyr)2295G-2b3Ove
(FVB/N-Abce1Tg(Tyr)2295G-2b3Ove)
complete embryonic lethality between implantation and somite formation J:175597
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6)
abnormal brown adipose tissue morphology J:122438
abnormal fat cell morphology J:122438
decreased susceptibility to diet-induced obesity J:122438
decreased susceptibility to hepatic steatosis J:122438
hyperactivity J:122438
hypoglycemia J:122438
increased body temperature J:122438
increased energy expenditure J:122438
increased oxygen consumption J:122438
Abcg1tm1Dgen/Abcg1+
Abcg4tm1Dgen/Abcg4tm1Dgen

(involves: 129P2/OlaHsd)
abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
decreased cholesterol efflux J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
(B6.Cg-Abcg1tm1Dgen)
abnormal lung morphology J:117028
abnormal macrophage physiology J:117028
abnormal phospholipid level J:117028
hepatic steatosis J:117028
increased cholesterol level J:117028
increased macrophage derived foam cell number J:117028
increased triglyceride level J:117028
renal/urinary system phenotype J:117028
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
abnormal chemokine secretion J:130777
abnormal cytokine secretion J:130777
abnormal leukocyte morphology J:132952
abnormal lung morphology J:132952
abnormal macrophage morphology J:132952
abnormal monocyte differentiation J:132952
abnormal surfactant secretion J:132952
decreased cholesterol efflux J:130777
increased B cell number J:132952
increased CD4-positive, alpha beta T cell number J:132952
increased CD8-positive, alpha-beta T cell number J:132952
increased dendritic cell number J:132952
increased eosinophil cell number J:132952
increased monocyte cell number J:132952
increased neutrophil cell number J:132952
lipidosis J:132952
lung inflammation J:132952
overexpanded pulmonary alveoli J:132952
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd)
abnormal lipid level J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
Abcg4tm1Dgen/Abcg4+

(involves: 129P2/OlaHsd)
abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
decreased cholesterol efflux J:141549
Abcg1tm1Dgen/Abcg1tm1Dgen
Abcg4tm1Dgen/Abcg4tm1Dgen

(involves: 129P2/OlaHsd)
abnormal cholesterol homeostasis J:141549
abnormal lipid homeostasis J:141549
abnormal lipid level J:141549
decreased cholesterol efflux J:141549
Abcg1tm1Yah/Abcg1+
(involves: 129P2/OlaHsd)
no phenotypic analysis J:154298
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB)
no phenotypic analysis J:165703
Abcg2tm1Ahs/Abcg2tm1Ahs
(either: (involves: 129P2/OlaHsd * FVB) or (involves: FVB))
abnormal bile color J:80519
hematopoietic system phenotype J:80519
homeostasis/metabolism phenotype J:80519
increased circulating bilirubin level J:80519
phototoxicity J:80519
porphyria J:80519
Abcg2tm1Ahs/Abcg2tm1Ahs
Tg(Thy1-AppDutch)#Jckr/0

(FVB.Cg-Abcg2tm1Ahs Tg(Thy1-AppDutch)#Jckr)
amyloid beta deposits J:178230
Abcg2tm1Ahs/Abcg2tm1Ahs
Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0

(FVB.Cg-Abcg2tm1Ahs Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr)
amyloid beta deposits J:178230
Abcg2tm1Bsor/Abcg2tm1Bsor
(involves: 129P2/OlaHsd * C57BL/6)
abnormal hematopoietic system morphology/development J:98134
increased physiological sensitivity to xenobiotic J:98134
Abcg2tm2Bsor/Abcg2tm2Bsor
(involves: 129S4/SvJae * C57BL/6)
no phenotypic analysis J:128682
Abcg2tm3.1(cre/ERT2)Bsor/Abcg2+
(involves: 129 * C57BL/6J)
no phenotypic analysis J:189206
Abcg4tm1Dgen/Abcg4tm1Dgen
(Not Specified)
abnormal lipid level J:141549
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal liver physiology J:87209
abnormal metabolism J:87209
abnormal phospholipid level J:87209
decreased cholesterol level J:87209
decreased circulating cholesterol level J:87209
enlarged liver J:87209
increased circulating plant sterol level J:87209
increased circulating triglyceride level J:87209
increased circulating VLDL triglyceride level J:87209
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd)
abnormal bile secretion J:112995
abnormal cholesterol homeostasis J:112995
abnormal lipid homeostasis J:112995
abnormal liver physiology J:112995
increased liver weight J:112995
Abcg5trac/Abcg5trac
(A/J-Abcg5trac)
abnormal circulating cholesterol level J:157223
abnormal circulating lipid level J:157223
abnormal erythrocyte osmotic lysis J:157223
abnormal megakaryocyte differentiation J:157223
abnormal megakaryocyte morphology J:157223
abnormal megakaryocyte progenitor cell morphology J:157223
abnormal neutrophil morphology J:157223
abnormal platelet activation J:157223
abnormal platelet morphology J:157223
abnormal platelet volume J:157223
abnormal spermatogenesis J:157223
anisocytosis J:157223
cardiac fibrosis J:157223
cardiomyopathy J:157223
decreased body size J:157223
decreased hematocrit J:157223
decreased leukocyte cell number J:157223
decreased platelet aggregation J:157223
decreased platelet cell number J:157223
female infertility J:157223
hemolytic anemia J:157223
hunched posture J:157223
increased bleeding time J:157223
increased mean platelet volume J:157223
increased megakaryocyte cell number J:157223
male infertility J:157223
premature death J:157223
reticulocytosis J:157223
stomatocytosis J:157223
Abcg8tm1Elk/Abcg8+
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal hepatobiliary system physiology J:94759
decreased circulating cholesterol level J:94759
Abcg8tm1Elk/Abcg8tm1Elk
(involves: 129S6/SvEvTac * C57BL/6J)
abnormal hepatobiliary system physiology J:94759
decreased cholesterol level J:94759
decreased circulating cholesterol level J:94759
increased circulating plant sterol level J:94759
increased circulating triglyceride level J:94759
Abfp4DBA/2/Abfp4DU6i
Abfp5DU6i/Abfp5DU6i

(involves: DBA/2 * DU6i)
abnormal abdominal fat pad morphology J:101006
Abhd2Gt(pUHachi)8025Imeg/Abhd2Gt(pUHachi)8025Imeg
(involves: C57BL/6NCrj * CBA/JNCrj)
abnormal cell migration J:96209
abnormal vascular wound healing J:96209
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu
Tg(Alb-cre)21Mgn/0

(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)
abnormal fatty acid oxidation J:199570
abnormal hepatocyte morphology J:199570
abnormal lipid level J:199570
abnormal liver morphology J:199570
abnormal liver physiology J:199570
abnormal phospholipid level J:199570
decreased triglyceride lipase activity J:199570
enlarged liver J:199570
hepatic steatosis J:199570
homeostasis/metabolism phenotype J:199570
increased circulating alanine transaminase level J:199570
increased circulating aspartate transaminase level J:199570
increased liver cholesterol level J:199570
increased liver free fatty acids level J:199570
increased liver triglyceride level J:199570
increased liver weight J:199570
liver fibrosis J:199570
liver inflammation J:199570
oxidative stress J:199570
pale liver J:199570
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6)
abnormal granulocyte morphology J:160725
abnormal keratinocyte differentiation J:160725
abnormal lipid homeostasis J:160725
abnormal lipid level J:160725
abnormal skin development J:160725
abnormal skin physiology J:160725
decreased birth body size J:160725
decreased birth weight J:160725
decreased body length J:160725
decreased circulating glucose level J:160725
decreased circulating triglyceride level J:160725
decreased fatty acid level J:160725
decreased triglyceride lipase activity J:160725
epidermis stratum spinosum hyperplasia J:160725
hepatic steatosis J:160725
hyperkeratosis J:160725
impaired lipolysis J:160725
impaired skin barrier function J:160725
increased liver triglyceride level J:160725
increased triglyceride level J:160725
neonatal lethality J:160725
Abhd5tm1a(KOMP)Wtsi/?
(Not Specified)
decreased bone trabecula number J:175295
increased trabecular bone thickness J:175295
Abhd5tm1Rze/Abhd5tm1Rze
Tg(Ckmm-cre)5Khn/0

(involves: 129P2/OlaHsd * C57BL/6 * FVB)
abnormal cardiac cell glucose uptake J:197835
abnormal glucose homeostasis J:197835
abnormal heart left ventricle morphology J:197835
abnormal lipid homeostasis J:197835
abnormal triglyceride level J:197835
decreased circulating free fatty acid level J:197835
decreased circulating glucose level J:197835
decreased circulating insulin level J:197835
decreased circulating triglyceride level J:197835
decreased lipoprotein lipase activity J:197835
decreased liver triglyceride level J:197835
decreased oxygen consumption J:197835
decreased ventricle muscle contractility J:197835
homeostasis/metabolism phenotype J:197835
impaired lipolysis J:197835
improved glucose tolerance J:197835
increased heart weight J:197835
increased left ventricle weight J:197835
increased respiratory quotient J:197835
increased triglyceride level J:197835
myocardial steatosis J:197835
premature death J:197835
Abhd12tm1Crv/Abhd12tm1Crv
(involves: C57BL/6)
abnormal auditory brainstem response waveform shape J:193716
abnormal phospholipid level J:193716
absent startle reflex J:193716
ataxia J:193716
decreased lipoprotein lipase activity J:193716
decreased startle reflex J:193716
hyperactivity J:193716
impaired coordination J:193716
impaired hearing J:193716
microgliosis J:193716
muscle weakness J:193716
vision/eye phenotype J:193716
Abi1tm1.1Lko/Abi1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
no phenotypic analysis J:171342
Abi1tm1.2Lko/Abi1tm1.2Lko
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)
abnormal pharyngeal arch development J:171342
cardiac edema J:171342
complete embryonic lethality during organogenesis J:171342
dilated heart J:171342
embryonic growth retardation J:171342
exencephaly J:171342
open neural tube J:171342
pericardial edema J:171342
wavy neural tube J:171342
Abi1tm1Pen/Abi1+
Abi2tm1Pen/Abi2tm1Pen

(Not Specified)
decreased interleukin-2 secretion J:104623
decreased T cell proliferation J:104623
immune system phenotype J:104623
Abi1tm1Pen/Abi1tm1Pen
(Not Specified)
complete embryonic lethality J:104623
Abi1tm1Pen/Abi1tm1Pen
(involves: CD-1)
abnormal chorion morphology J:169009
abnormal endocardium morphology J:169009
abnormal epicardium morphology J:169009
abnormal heart layer morphology J:169009
abnormal vitelline vasculature morphology J:169009
complete embryonic lethality during organogenesis J:169009
decreased angiogenesis J:169009
disorganized myocardium J:169009
edema J:169009
embryonic growth retardation J:169009
increased Reichert's membrane thickness J:169009
internal hemorrhage J:169009
Abi1tm1Pen/Abi1tm1Pen
(involves: C57BL/6)
abnormal chorion morphology J:169009
abnormal vasculogenesis J:169009
complete embryonic lethality J:169009
embryonic growth retardation J:169009
failure of chorioallantoic fusion J:169009
Abi1tm1Pen/Abi1tm1Pen
Abi2tm1Pen/Abi2+

(Not Specified)
abnormal cell physiology J:169009
Abi2tm1Pen/Abi2+
(B6.Cg-Abi2tm1Pen)
abnormal contextual conditioning behavior J:95254
abnormal hippocampus CA1 region morphology J:95254
abnormal hippocampus pyramidal cell morphology J:95254
Abi2tm1Pen/Abi2tm1Pen
(B6.Cg-Abi2tm1Pen)
abnormal cerebral cortex morphology J:95254
abnormal cerebral cortex pyramidal cell morphology J:95254
abnormal contextual conditioning behavior J:95254
abnormal corpus callosum morphology J:95254
abnormal dentate gyrus morphology J:95254
abnormal hippocampus CA1 region morphology J:95254
abnormal hippocampus morphology J:95254
abnormal hippocampus pyramidal cell layer J:95254
abnormal lens capsule morphology J:95254
abnormal lens development J:95254
abnormal lens morphology J:95254
disorganized secondary lens fibers J:95254
microphthalmia J:95254
Abl1m1/Abl1+
(involves: 129S/SvEv)
no abnormal phenotype detected J:72519
Abl1m1/Abl1m1
(either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))
abnormal B cell differentiation J:14644
abnormal immune system cell morphology J:14644
abnormal immune system organ morphology J:14644
abnormal spleen germinal center morphology J:14644
abnormal spleen morphology J:14644
abnormal spleen white pulp morphology J:14644
abnormal T cell number J:14644
abnormal thymus morphology J:14644
cataracts J:14644
decreased body weight J:14644
decreased cranium height J:14644
decreased immature B cell number J:14644
decreased pre-B cell number J:14644
decreased pro-B cell number J:14644
decreased single-positive T cell number J:14644
decreased thymocyte number J:14644
eyelids open at birth J:14644
increased single-positive T cell number J:14644
increased susceptibility to infection J:14644
partial postnatal lethality J:14644
premature death J:14644
spleen hypoplasia J:14644
thymus cortex hypoplasia J:14644
thymus hypoplasia J:14644
Abl1m1/Abl1m1
(involves: 129S/SvEv)
abnormal B cell differentiation J:28795
abnormal bone marrow cell physiology J:28795
abnormal immune system cell morphology J:34903
abnormal splenocyte physiology J:34903
decreased mature B cell number J:28795
decreased pre-B cell number J:28795
decreased pro-B cell number J:28795
Abl1m1/Abl1m1
(involves: 129S/SvEv * C57BL/6)
abnormal B cell physiology J:148105
abnormal bone marrow cell physiology J:148105
abnormal lymphopoiesis J:148105
decreased pro-B cell number J:148105
Abl1m1/Abl1m1
(B6.129-Abl1m1)
partial perinatal lethality J:156743
Abl1tm1.1Gcos/Abl1+
(involves: 129S1/Sv * 129X1/SvJ)
abnormal myogenesis J:168843
decreased physiological sensitivity to xenobiotic J:168843
Abl1tm1.1Gcos/Abl1tm1.1Gcos
(involves: 129S1/Sv * 129X1/SvJ)
abnormal myogenesis J:168843
decreased physiological sensitivity to xenobiotic J:168843
Abl1tm1.1Goff/Abl1tm1.1Goff
(involves: C57BL/6)
no abnormal phenotype detected J:156743
Abl1tm1Ajk/Abl1tm1Ajk
Abl2tm1Ajk/Abl2tm1Ajk
Tg(Nes-cre)1Kag/?

(involves: 129S4/SvJae)
abnormal cerebral cortex pyramidal cell morphology J:99296
mortality/aging J:99296
Abl1tm1Gcos/Abl1+
Myf5tm2Tajb/Myf5tm2Tajb
Myf6tm1Tajb/Myf6tm1Tajb
Myod1tm2.1(icre)Glh/Myod1+

(involves: 129S * 129X1/SvJ * C57BL/6J)
abnormal myogenesis J:168843
decreased physiological sensitivity to xenobiotic J:168843
Abl1tm1Goff/Abl1tm1Goff
(involves: C57BL/6)
abnormal heart ventricle morphology J:156743
enlarged heart J:156743
heart hyperplasia J:156743
partial perinatal lethality J:156743
thick ventricular wall J:156743
Abl1tm1Goff/Abl1tm1Goff
Tg(Myh6-cre)2182Mds/0

(involves: C57BL/6)
cardiovascular system phenotype J:156743
complete neonatal lethality J:156743
thick ventricular wall J:156743
Abl1tm1Mlg/Abl1+
Abl2tm1Ajk/Abl2tm1Ajk

(involves: 129S/SvEv * 129S4/SvJae * C57BL/6J)
decreased body size J:51887
partial postnatal lethality J:51887
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J)
abnormal esophagus morphology J:72875
abnormal hepatocyte morphology J:72875
cachexia J:72875
cardiovascular system phenotype J:156743
decreased B cell number J:72875
decreased lymphocyte cell number J:72875
decreased survivor rate J:72875
decreased T cell number J:72875
decreased thymocyte number J:72875
lung inflammation J:72875
partial perinatal lethality J:156743
partial postnatal lethality J:72875, J:156743
rectal prolapse J:72875
spleen atrophy J:72875
thymus atrophy J:72875
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * CBA * C57BL/6J)
abnormal eye morphology J:34643
abnormal spleen morphology J:34643
decreased body size J:34643
decreased bone marrow cell number J:34643
decreased cranium height J:34643
decreased survivor rate J:34643
increased susceptibility to infection J:34643
partial postnatal lethality J:34643
rectal prolapse J:34643
Abl1tm1Mlg/Abl1tm1Mlg
(129S/SvEv-Abl1tm1Mlg)
partial postnatal lethality J:156743
Abl1tm1Mlg/Abl1tm1Mlg
(B6.129-Abl1tm1Mlg)
abnormal heart morphology J:156743
abnormal heart ventricle morphology J:156743
abnormal myocardial fiber morphology J:156743
abnormal myocardium compact layer morphology J:156743
abnormal trabecula carnea morphology J:156743
dilated heart atrium J:156743
disorganized myocardium J:156743
enlarged heart J:156743
heart hyperplasia J:156743
increased fetal cardiomyocyte proliferation J:156743
increased heart ventricle size J:156743
increased heart weight J:156743
increased myocardial fiber number J:156743
partial neonatal lethality J:156743
partial postnatal lethality J:156743
thick interventricular septum J:156743
thick ventricular wall J:156743
Abl1tm1Mlg/Abl1tm1Mlg
Abl2tm1Ajk/Abl2+

(involves: 129S/SvEv * 129S4/SvJae * C57BL/6J)
abnormal peritoneum morphology J:51887
distended pericardium J:51887
edema J:51887
hemopericardium J:51887
hemoperitoneum J:51887
partial lethality throughout fetal growth and development J:51887
pericardial edema J:51887
Abl1tm1Mlg/Abl1tm1Mlg
Abl2tm1Ajk/Abl2tm1Ajk

(involves: 129S/SvEv * 129S4/SvJae * C57BL/6J)
abnormal embryonic neuroepithelium morphology J:51887
abnormal neuron differentiation J:51887
complete embryonic lethality during organogenesis J:51887
delayed neural tube closure J:51887
hemopericardium J:51887
increased apoptosis J:51887
Abl1tm1Mlg/Abl1tm1Mlg
Tg(ACTB-Abl1*I)1Spg/0

(involves: 129S/SvEv * CBA * C57BL/6J)
decreased bone marrow cell number J:34643
mortality/aging J:34643
Abl1tm1Mlg/Abl1tm1Mlg
Tg(ACTB-Abl1*I)1Spg/0
Tg(ACTB-Abl1*IV)1Spg/0

(involves: 129S/SvEv * CBA * C57BL/6J)
mortality/aging J:34643
Abl1tm1Mlg/Abl1tm1Mlg
Tg(ACTB-Abl1*IV)1Spg/0

(involves: 129S/SvEv * CBA * C57BL/6J)
decreased bone marrow cell number J:34643
mortality/aging J:34643
Abl1tm1Mlg/Abl1tm1Mlg
Tg(ACTB-Abl1*K290R)1Spg/0

(involves: 129S/SvEv * CBA * C57BL/6J)
abnormal digestive system morphology J:34643
abnormal spleen morphology J:34643
decreased survivor rate J:34643
increased susceptibility to infection J:34643
partial postnatal lethality J:34643
Abl1tm2.1Goff/Abl1tm2.1Goff
Abl2tm1Ajk/Abl2tm1Ajk
Tg(Atoh1-cre)1Bfri/0

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CBA)
nervous system phenotype J:166211
Abl1tm2.1Goff/Abl1tm2.1Goff
Abl2tm1Ajk/Abl2tm1Ajk
Tg(Nes-cre)1Kln/0

(involves: 129 * C57BL/6 * C57BL/6J * SJL)
abnormal brain morphology J:166211
abnormal cerebellar granule cell proliferation J:166211
abnormal cerebellar layer morphology J:166211
abnormal cerebellar lobule formation J:166211
abnormal cerebellum fissure morphology J:166211
abnormal cerebellum morphology J:166211
abnormal cerebellum white matter morphology J:166211
absent cerebellar lobules J:166211
absent cerebellum fissure J:166211
ectopic Bergmann glia cells J:166211
ectopic cerebellar granule cells J:166211
ectopic Purkinje cell J:166211
impaired coordination J:166211
partial postnatal lethality J:166211
reduced cerebellar foliation J:166211
small cerebellum J:166211
Abl1tm2.2Goff/Abl1tm2.2Goff
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
abnormal cerebellar foliation J:166211
abnormal cerebellum development J:166211
decreased body size J:166211
ectopic cerebellar granule cells J:166211
partial neonatal lethality J:166211
spleen atrophy J:166211
thymus atrophy J:166211
Abl2Gt(kin)Byg/Abl2Gt(kin)Byg
(involves: 129 * C57BL/6)
nervous system phenotype J:161269
transmission ratio distortion J:161269
Abl2tm1Ajk/Abl2tm1Ajk
(involves: 129S4/SvJae * C57BL/6J)
abnormal motor coordination/ balance J:51887
absent startle reflex J:51887
decreased aggression J:51887
decreased body weight J:51887
decreased startle reflex J:51887
impaired coordination J:51887
novel environmental response-related retropulsion J:51887
reduced fertility J:51887
Abl2tm1Ajk/Abl2tm1Ajk
(involves: 129S4/SvJae)
abnormal cerebral cortex pyramidal cell morphology J:99296
Ablim1tm1Tili/Ablim1tm1Tili
(involves: 129/Sv * C57BL/6)
no abnormal phenotype detected J:84905
AblpBALB/cJ/?
(involves: BALB/cJ * C57BL/6J)
abnormal enzyme/ coenzyme level J:94275
AbmmDBA/2J/?
(involves: BALB/cByJ * DBA/2J)
myocarditis J:52296
abn/abn
(STOCK tlow)
cleft palate J:28671
complete prenatal lethality J:28671
enlarged liver J:28671
protruding tongue J:28671
short limbs J:28671
shortened head J:28671
Abrtm1Jhg/Abrtm1Jhg
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
no abnormal phenotype detected J:72425
Abrtm1Jhg/Abrtm1Jhg
Bcrtm1Hkp/Bcrtm1Hkp

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * Black Swiss * C57BL/6)
abnormal astrocyte morphology J:72425
abnormal astrocyte physiology J:72425
abnormal cerebellar foliation J:72425
abnormal cerebellum morphology J:72425
abnormal CNS glial cell morphology J:72425
abnormal ear development J:108010
abnormal inner ear vestibule morphology J:108010
abnormal radial glial cell morphology J:72425
abnormal utricle morphology J:108010
abnormal vestibular saccule morphology J:108010
absent otoliths J:108010, J:72425
circling J:108010, J:72425
decreased otolith number J:108010
ectopic cerebellar granule cells J:72425
enlarged otoliths J:108010
gliosis J:72425
hearing/vestibular/ear phenotype J:108010
hyperactivity J:108010, J:72425
impaired balance J:108010
impaired coordination J:108010, J:72425
impaired swimming J:108010
partial neonatal lethality J:72425
Abratm1Eno/Abratm1Eno
(Not Specified)
abnormal artery development J:167793
increased susceptibility to injury J:167793
Abshq1PWK/PhJ/Abshq1PWK/PhJ
(involves: LEWES/EiJ * PWK/PhJ)
abnormal sperm head morphology J:139578
Abshq2PWK/PhJ/Abshq2PWK/PhJ
(involves: LEWES/EiJ * PWK/PhJ)
abnormal sperm head morphology J:139578
Abshq3PWK/PhJ/Abshq3PWK/PhJ
(involves: LEWES/EiJ * PWK/PhJ)
abnormal sperm head morphology J:139578
Abshq4PWK/PhJ/Abshq4PWK/PhJ
(involves: LEWES/EiJ * PWK/PhJ)
abnormal sperm head morphology J:139578
Abshq5PWK/PhJ/Abshq5PWK/PhJ
(involves: LEWES/EiJ * PWK/PhJ)
abnormal sperm head morphology J:139578
Abshq6PWK/PhJ/Abshq6PWK/PhJ
(involves: LEWES/EiJ * PWK/PhJ)
abnormal sperm head morphology J:139578
Abshq7PWK/PhJ/Abshq7PWK/PhJ
(involves: LEWES/EiJ * PWK/PhJ)
abnormal sperm head morphology J:139578
ac/ac
(Not Specified)
absent corpus callosum J:14887
Acaa1btm1Vnf/Acaa1btm1Vnf
(involves: 129S4/SvJae * C57BL/6J)
no abnormal phenotype detected J:105494
Acacatm1.1Jkus/Acacatm1.1Jkus
(involves: 129X1/SvJ * C57BL/6J)
embryonic growth retardation J:118861
embryonic lethality during organogenesis J:118861
Acacatm1Jkus/Acacatm1Jkus
Tg(Fabp1-cre)1Mmt/0

(involves: 129X1/SvJ * C57BL/6J * SJL)
abnormal lipid homeostasis J:118861
decreased liver triglyceride level J:118861
increased circulating aspartate transaminase level J:118861
Acacatm1Sjw/Acacatm1Sjw
(involves: 129S7/SvEvBrd * C57BL/6J)
complete embryonic lethality between implantation and somite formation J:101150
decreased embryo size J:101150
embryonic growth arrest J:101150
Acacatm2Sjw/Acacatm2Sjw
Tg(Alb-cre)21Mgn/0

(involves: 129S7/SvEvBrd * C57BL/6J * FVB)
abnormal enzyme/coenzyme activity J:110200
abnormal glucose homeostasis J:110200
abnormal lipid level J:110200
abnormal liver physiology J:110200
decreased circulating free fatty acid level J:110200
decreased circulating ketone body level J:110200
decreased fatty acid level J:110200
decreased liver triglyceride level J:110200
decreased susceptibility to hepatic steatosis J:110200
hyperglycemia J:110200
increased circulating free fatty acid level J:110200
increased circulating insulin level J:110200
Acacbtm1.1Lowl/Acacbtm1.1Lowl
Tg(Myog-cre)1Eno/0

(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
no abnormal phenotype detected J:159285
Acacbtm1.2Lowl/Acacbtm1.2Lowl
(involves: 129S6/SvEvTac * FVB/N)
abnormal behavior J:159285
abnormal enzyme/ coenzyme level J:159285
decreased respiratory quotient J:159285
homeostasis/metabolism phenotype J:159285
increased circulating insulin level J:159285
increased oxygen consumption J:159285
small heart J:159285
Acacbtm1.2Lowl/Acacbtm1.2Lowl
Lepob/Lepob

(involves: 129S6/SvEvTac * FVB/N)
increased body weight J:159285
Acacbtm1Dejs/Acacbtm1Dejs
(C57BL/6-Acacbtm1Dejs)
abnormal aerobic respiration J:157000
abnormal fatty acid oxidation J:157000
abnormal glucose homeostasis J:157000
abnormal lipid homeostasis J:157000
growth/size/body phenotype J:157000
homeostasis/metabolism phenotype J:157000
increased skeletal muscle glycogen level J:157000
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified)
abnormal energy expenditure J:68427
abnormal enzyme/ coenzyme level J:68427
abnormal fatty acid beta-oxidation J:68427
abnormal fatty acid oxidation J:68427
abnormal lipid homeostasis J:68427
decreased body weight J:68427
decreased circulating leptin level J:68427
decreased fatty acid level J:68427
decreased glycogen level J:68427
decreased subcutaneous adipose tissue amount J:68427
decreased total body fat amount J:68427
hypoglycemia J:68427
increased circulating ketone body level J:68427
increased circulating triglyceride level J:68427
polyphagia J:68427
Acadltm1Uab/Acadl+
(involves: 129S6/SvEvTac * C57BL/6NTac)
decreased litter size J:51660
partial prenatal lethality J:51660
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac)
abnormal adaptive thermogenesis J:50729
abnormal bile composition J:51660
abnormal enzyme/coenzyme activity J:72193, J:51660
abnormal heart morphology J:72193, J:51660
abnormal lipid homeostasis J:72193
aciduria J:72193, J:51660
cardiac fibrosis J:51660
decreased litter size J:72193, J:51660
hepatic steatosis J:72193, J:51660
hypoglycemia J:51660
increased circulating carnitine level J:72193
increased circulating free fatty acid level J:51660
increased fatty acid level J:72193
increased unsaturated fatty acid level J:51660
lipidosis J:51660
partial prenatal lethality J:51660
premature death J:51660
Acadltm1Uab/Acadltm1Uab
Acadvltm1Uab/Acadvltm1Uab

(involves: 129S6/SvEvTac * C57BL/6NTac)
postnatal lethality J:72193
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6)
abnormal aorta elastic tissue morphology J:115759
abnormal blood homeostasis J:115759
abnormal myocardial fiber morphology J:115759
cardiac fibrosis J:115759
cardiomyopathy J:115759
decreased circulating glucose level J:115759
hepatic steatosis J:115759
impaired adaptive thermogenesis J:115759
increased circulating carnitine level J:115759
myocardial fiber degeneration J:115759
partial postnatal lethality J:115759
Acadsdel-J/Acads+
Otcspf/Y

(involves: BALB/cByJ * CD-1)
aciduria J:4165
oroticaciduria J:4165
Acadsdel-J/Acadsdel-J
(BALB/cByJ)
abnormal adaptive thermogenesis J:50729
abnormal circulating amino acid level J:14707
abnormal fatty acid oxidation J:14707
abnormal food preference J:87779
abnormal liquid preference J:87779
abnormal skeletal muscle morphology J:14707
aciduria J:9743, J:4165, J:14707
decreased circulating carnitine level J:14707
hepatic steatosis J:14707
hypoglycemia J:14707
increased circulating HDL cholesterol level J:164460
Acadsdel-J/Acadsdel-J
Otcspf/Y

(involves: BALB/cByJ * CD-1)
aciduria J:4165
premature death J:4165
sparse hair J:4165
Acadsdel-J/Acadsdel-J
Otcspf/Otc+

(involves: BALB/cByJ * CD-1)
aciduria J:4165
Acadsdel-J/Acadsdel-J
Otcspf/Otcspf

(involves: BALB/cByJ * CD-1)
oroticaciduria J:4165
premature death J:4165
AcadsHdlq8-C57BL/6J/AcadsHdlq8-C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
decreased circulating HDL cholesterol level J:84430
AcadsHdlq8-NZB/BlNJ/AcadsHdlq8-NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
increased circulating HDL cholesterol level J:84430
Acadvltm1Uab/Acadvltm1Uab
(involves: 129S6/SvEvTac * C57BL/6)
abnormal enzyme/coenzyme activity J:72193
abnormal heart morphology J:72193
abnormal lipid homeostasis J:72193
hepatic steatosis J:72193
increased circulating carnitine level J:72193
Acadvltm1Vje/Acadvl+
(involves: 129/Sv * C57BL/6)
abnormal amino acid level J:102010
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * C57BL/6)
abnormal adipose tissue morphology J:102010
abnormal amino acid level J:102010
abnormal myocardial fiber morphology J:98627
abnormal skeletal muscle fiber morphology J:98627
cardiomyopathy J:98627
fatigue J:102010
impaired adaptive thermogenesis J:102010
impaired glucose tolerance J:102010
increased body weight J:102010
increased sensitivity to induced morbidity/mortality J:102010
increased tumor incidence J:102010
irregular heartbeat J:98627
myocardial fiber degeneration J:98627
premature death J:102010
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6)
abnormal adipose tissue physiology J:106714
abnormal amino acid level J:106714
abnormal brown adipose tissue morphology J:106714
abnormal cellular respiration J:106714
abnormal myocardial fiber morphology J:106714
decreased glycogen level J:106714
decreased heart rate J:106714
hepatic steatosis J:106714
hypoglycemia J:106714
impaired adaptive thermogenesis J:106714
increased sensitivity to induced morbidity/mortality J:106714
Acadvltm1Zkhu/Acadvltm1Zkhu
Tg(Myh6-cre)1Jmk/0

(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)
abnormal adaptive thermogenesis J:208711
abnormal cardiovascular system physiology J:208711
abnormal heart left ventricle morphology J:208711
abnormal heart morphology J:208711
abnormal myocardial fiber morphology J:208711
decreased circulating glucose level J:208711
decreased core body temperature J:208711
decreased heart rate J:208711
decreased respiratory quotient J:208711
decreased ventricle muscle contractility J:208711
dilated cardiomyopathy J:208711
dilated heart left ventricle J:208711
increased heart weight J:208711
increased sensitivity to induced morbidity/mortality J:208711
lethargy J:208711
Acanb2b183Clo/Acanb2b183Clo
(C57BL/6J-Acanb2b183Clo)
brachypodia J:175213
cardiac hypertrophy J:175213
cardiomyopathy J:175213
cleft palate J:175213
disproportionate dwarf J:175213
Acancmd-Bc/Acancmd-Bc
(BALB/cGaBc)
abnormal limb development J:58755
cleft palate J:58755
complete neonatal lethality J:65316
distended abdomen J:58755
protruding tongue J:58755
pulmonary hypoplasia J:65316
respiratory failure J:65316
short limbs J:65316
short snout J:58755
small thoracic cavity J:65316
Acancmd/Acan+
(involves: STOCK T tlow Itpr3tf)
abnormal gait J:41498
abnormal intervertebral disk morphology J:41498
abnormal spinal cord morphology J:41498
abnormal vertebral body morphology J:41498
aphagia J:41498
disproportionate dwarf J:41498
intervertebral disk degeneration J:41498
kyphosis J:41498
lordosis J:41498
premature death J:41498
Acancmd/Acancmd
(STOCK T tlow Itpr3tf)
abnormal basicranium morphology J:30795
abnormal cartilage development J:30795
abnormal chondrocyte morphology J:30795, J:5952
abnormal craniofacial bone morphology J:30795
abnormal limb morphology J:30795
abnormal liver morphology J:5952
abnormal rib morphology J:30795
abnormal snout morphology J:5952
abnormal trabecular bone morphology J:30795
abnormal tracheal cartilage morphology J:5952
abnormal vertebrae morphology J:30795, J:5952
absent caudal vertebrae J:30795
brachydactyly J:30795
cleft palate J:30795, J:5952
complete neonatal lethality J:5952
decreased length of long bones J:5952
disproportionate dwarf J:30795
distended abdomen J:30795, J:5952
enlarged liver J:5952
protruding tongue J:5952
respiratory distress J:5952
short femur J:5952
short humerus J:5952
short snout J:5952
short vertebral column J:30795, J:5952
Acancmd/Acancmd
(involves: STOCK T tlow Itpr3tf)
abnormal cartilage development J:1535
abnormal cochlear IHC afferent innervation pattern J:553
abnormal cochlear inner hair cell morphology J:553
abnormal lung morphology J:23353
abnormal organ of Corti morphology J:553
absent cochlear outer hair cells J:553
cleft palate J:553
complete neonatal lethality J:553
deafness J:553
disproportionate dwarf J:553
increased or absent threshold for auditory brainstem response J:553
polyhydramnios J:23353
pulmonary hypoplasia J:23353
small thoracic cavity J:23353
Acantm1(cre/ERT2)Crm/Acantm1(cre/ERT2)Crm
(involves: 129S6/SvEvTac * C57BL/6)
no abnormal phenotype detected J:155982
Acantm1Afos/Acantm1Afos
(involves: C57BL/6)
no abnormal phenotype detected J:97622
Acantm2Afos/Acantm2Afos
(involves: C57BL/6)
decreased susceptibility to induced arthritis J:122102
Acap3tm1a(EUCOMM)Hmgu/Acap3tm1a(EUCOMM)Hmgu
(Not Specified)
abnormal bone mineralization J:165965
abnormal bone structure J:165965
decreased body length J:165965
decreased body weight J:165965
decreased bone mineral content J:165965
decreased lean body mass J:165965
short tibia J:165965
Acc/Acc
(involves: 101 * C3H)
complete prenatal lethality J:6686
Acc/Acc+
(involves: 101 * C3H)
abnormal pupil morphology J:6686, J:9528
anterior polar cataracts J:6686, J:9528
corneal opacity J:9528
sutural cataracts J:6686, J:9528
Acdacd/Acdacd
(involves: DW/J)
abnormal adrenal gland morphology J:14144
abnormal ear pigmentation J:14144
abnormal hair texture J:14144
abnormal kidney morphology J:14144
curly vibrissae J:14144
hyperpigmentation J:14144
kinked tail J:14144
polydactyly J:14144
premature death J:14144
reduced fertility J:14144
retarded hair growth J:14144
short vibrissae J:14144
sparse hair J:14144
Acdacd/Acdacd
(DW/J-Acdacd Pou1f1+)
abnormal adrenal gland morphology J:18027
abnormal adrenocorticotropin level J:18027
abnormal corticosterone level J:18027
abnormal pituitary hormone level J:18027
adrenal gland hypoplasia J:18027
decreased circulating corticosterone level J:18027
increased adrenocorticotropin level J:18027
small adrenal glands J:18027
Acdtm1.1Blas/Acdtm1.1Blas
Tg(KRT5-cre)1Tak/?

(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6 * SJL)
abnormal cell cycle J:160600
abnormal cell cycle checkpoint function J:160600
abnormal cell nucleus morphology J:160600
abnormal coat/ hair morphology J:160600
abnormal epidermal layer morphology J:160600
abnormal hair follicle development J:160600
abnormal mitosis J:160600
abnormal mucosal lining of the mouth J:160600
abnormal skin appearance J:160600
abnormal skin morphology J:160600
abnormal skin pigmentation J:160600
abnormal telomere length J:160600
absent hair follicles J:160600
absent sebaceous gland J:160600
aphagia J:160600
complete postnatal lethality J:160600
dry skin J:160600
impaired skin barrier function J:160600
polyploidy J:160600
postnatal growth retardation J:160600
preneoplasia J:160600
scaly skin J:160600
Acdtm1.1Cek/Acdtm1.1Cek
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * SJL)
abnormal cell physiology J:160503
abnormal chromosome morphology J:160503
early cellular replicative senescence J:160503
polyploidy J:160503
Acdtm1.2Cek/Acdtm1.2Cek
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * FVB/N * SJL)
complete embryonic lethality during organogenesis J:160503
Ace2tm1Cof/Y
(involves: 129S6/SvEvTac * C57BL/6J)
decreased heart rate J:113108
increased systemic arterial systolic blood pressure J:113108
Ace2tm1Cof/Y
(B6.129S6-Ace2tm1Cof)
increased systemic arterial systolic blood pressure J:113108
Ace2tm1Cof/Y
(129S6/SvEvTac-Ace2tm1Cof)
cardiovascular system phenotype J:113108
hypertension J:113108
increased circulating angiotensinogen level J:113108
Ace2tm1Hira/Y
(involves: 129S7/SvEvBrd * C57BL/6)
abnormal circulating angiotensinogen level J:135766
cardiac fibrosis J:135766
cardiac interstitial fibrosis J:135766
congestive heart failure J:135766
decreased ventricle muscle contractility J:135766
dilated heart left ventricle J:135766
increased heart weight J:135766
increased lung weight J:135766
increased sensitivity to induced morbidity/mortality J:135766
pulmonary vascular congestion J:135766
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
decreased cardiac muscle contractility J:77232
hypotension J:77232
thin ventricular wall J:77232
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
decreased cardiac muscle contractility J:77232
Ace3tm1Osb/Ace3tm1Osb
(involves: 129/Sv * C57BL/6)
reproductive system phenotype J:160139
Acetm1Keb/Ace+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
cardiovascular system phenotype J:33018
Acetm1Keb/Acetm1Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal kidney arterial blood vessel morphology J:33018
abnormal kidney corticomedullary boundary morphology J:33018
abnormal kidney papilla morphology J:33018
abnormal renal artery morphology J:33018
abnormal urine homeostasis J:33018
decreased kidney weight J:33018
decreased litter size J:33018
decreased systemic arterial systolic blood pressure J:33018
decreased urine aldosterone level J:33018
decreased urine osmolality J:33018
dilated kidney calyx J:33018
hydronephrosis J:33018
increased circulating creatinine level J:33018
increased heart rate J:33018
increased urine potassium level J:33018
kidney inflammation J:33018
kidney medulla atrophy J:33018
kidney papillary atrophy J:33018
mortality/aging J:33018
polyuria J:33018
reduced male fertility J:33018
Acetm1Keb/Acetm1Keb
(involves: 129S1/Sv * 129X1/SvJ)
abnormal response/metabolism to endogenous compounds J:163902
abnormal systemic arterial blood pressure J:163902
increased renin activity J:163902
Acetm1Keb/Acetm5Keb
(involves: 129S1/Sv * 129X1/SvJ)
abnormal enzyme/coenzyme activity J:89512
increased circulating renin level J:89512
Acetm1Mcf/Acetm1Mcf
(Not Specified)
abnormal kidney blood vessel morphology J:32114
abnormal kidney medulla morphology J:32114
abnormal kidney medullary ray morphology J:32114
abnormal kidney pelvis morphology J:32114
decreased urine osmolality J:32114
dilated renal glomerular capsule J:32114
increased blood urea nitrogen level J:32114
kidney cortex atrophy J:32114
kidney inflammation J:32114
kidney medulla cysts J:32114
partial postnatal lethality J:32114
reproductive system phenotype J:32114
tubulointerstitial nephritis J:32114
Acetm1Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal epididymal fat pad morphology J:128859
hypotension J:25284
increased body weight J:128859
increased insulin secretion J:128859
partial postnatal lethality J:25284
reproductive system phenotype J:46177
Acetm1Unc/Ace+
(B6.129P2-Acetm1Unc)
homeostasis/metabolism phenotype J:72577
Acetm1Unc/Ace+
(involves: 129P2/OlaHsd)
increased heart rate J:42519
increased heart weight J:42519
Acetm1Unc/Acetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal kidney blood vessel morphology J:25284
abnormal male reproductive system physiology J:46177
abnormal renal glomerulus morphology J:25284
decreased litter size J:25284
hypotension J:25284
impaired fertilization J:46177
kidney cortex atrophy J:25284
kidney inflammation J:25284
partial postnatal lethality J:25284
reduced male fertility J:25284
renal tubule atrophy J:25284
Acetm1Unc/Acetm1Unc
Ace2tm1Pngr/Y

(involves: 129P2/OlaHsd)
abnormal kidney morphology J:77232
hypotension J:77232
Acetm1Unc/Acetm1Unc
Ace2tm1Pngr/Ace2tm1Pngr

(involves: 129P2/OlaHsd)
abnormal kidney morphology J:77232
hypotension J:77232
Acetm2Keb/Ace+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased systemic arterial systolic blood pressure J:40475
Acetm2Keb/Acetm2Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal kidney arterial blood vessel morphology J:40475
decreased litter size J:40475
decreased systemic arterial systolic blood pressure J:40475
decreased urine osmolality J:40475
dilated kidney calyx J:40475
increased glomerular capsule space J:40475
polyuria J:40475
reduced male fertility J:40475
Acetm2Unc/Acetm2Unc
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal kidney blood vessel morphology J:46177
kidney atrophy J:46177
partial postnatal lethality J:46177
reproductive system phenotype J:46177
Acetm3Keb/Acetm3Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
cardiovascular system phenotype J:83178
liver/biliary system phenotype J:83178
renal/urinary system phenotype J:83178
Acetm3Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal epididymal fat pad morphology J:128859
abnormal kidney cortex morphology J:42519
abnormal renal glomerulus morphology J:42519
decreased body weight J:128859
decreased heart rate J:42519
decreased heart weight J:42519
decreased insulin secretion J:128859
increased food intake J:128859
Acetm3Unc/Ace+
(B6.129P2-Acetm3Unc)
albuminuria J:72577
increased systemic arterial blood pressure J:72577
Acetm3Unc/Acetm3Unc
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal kidney cortex morphology J:42519
abnormal renal glomerulus morphology J:42519
decreased heart rate J:42519
decreased heart weight J:42519
Acetm4Keb/Acetm4Keb
(involves: 129S1/Sv * 129X1/SvJ)
abnormal kidney blood vessel morphology J:83894
abnormal kidney morphology J:83894
abnormal kidney pelvis morphology J:83894
decreased hematocrit J:83894
decreased kidney weight J:83894
decreased systemic arterial systolic blood pressure J:83894
decreased urine osmolality J:83894
kidney medulla hypoplasia J:83894
Acetm4Keb/Acetm4Keb
Bdkrb2tm1Jfh/Bdkrb2tm1Jfh

(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
abnormal kidney blood vessel morphology J:83894
abnormal response/metabolism to endogenous compounds J:83894
decreased hematocrit J:83894
decreased kidney weight J:83894
decreased systemic arterial systolic blood pressure J:83894
decreased urine osmolality J:83894
kidney cysts J:83894
vasculitis J:83894
Acetm5Keb/Acetm5Keb
(involves: 129S1/Sv * 129X1/SvJ)
abnormal enzyme/coenzyme activity J:89512
cardiovascular system phenotype J:89512
homeostasis/metabolism phenotype J:163902
renal/urinary system phenotype J:89512
Acetm5Keb/Acetm5Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased sensitivity to xenobiotic induced morbidity/mortality J:163454
decreased susceptibility to injury J:163454
increased angiotensin I-converting enzyme activity J:163454
Acetm6Keb/Ace+
(involves: 129 * C57BL/6)
decreased tumor growth/size J:122178
Acetm6Keb/Acetm6Keb
(involves: 129 * C57BL/6)
abnormal interleukin level J:122178
altered tumor morphology J:122178
decreased tumor growth/size J:122178
increased T cell number J:122178
Acetm6Keb/Acetm6Keb
(involves: 129 * C57BL/6 * CD-1)
decreased tumor growth/size J:122178
Acetm7Keb/Acetm7Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
atrial fibrillation J:92397
decreased survivor rate J:92397
decreased systemic arterial systolic blood pressure J:92397
dilated heart J:92397
enlarged heart atrium J:92397
premature death J:92397
Acetm8.1Keb/Acetm8.1Keb
(involves: 129 * C57BL/6 * FVB/N)
abnormal circulating protein level J:163902
abnormal enzyme/coenzyme activity J:163902
abnormal response/metabolism to endogenous compounds J:163902
abnormal systemic arterial blood pressure J:163902
cardiovascular system phenotype J:163902
decreased angiotensin I-converting enzyme activity J:163902
decreased urine osmolality J:163902
increased renin activity J:163902
renal/urinary system phenotype J:163902
Acetm8.1Keb/Acetm8.1Keb
(involves: 129 * C57BL/6)
decreased angiotensin I-converting enzyme activity J:163454
homeostasis/metabolism phenotype J:163454
Acetm8Keb/Acetm8Keb
(involves: 129)
abnormal cardiovascular system physiology J:163902
abnormal homeostasis J:163902
abnormal kidney morphology J:163902
Acetm9Keb/Acetm9Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
abnormal circulating angiotensinogen level J:185888
abnormal kidney medulla morphology J:185888
abnormal kidney pelvis morphology J:185888
abnormal renal artery morphology J:185888
abnormal systemic arterial blood pressure J:185888
abnormal urine osmolality J:185888
decreased angiotensin I-converting enzyme activity J:185888
decreased circulating angiotensinogen level J:185888
decreased systemic arterial systolic blood pressure J:185888
decreased urine osmolality J:185888
homeostasis/metabolism phenotype J:185888
increased fluid intake J:185888
increased renin activity J:185888
kidney inflammation J:185888
polyuria J:185888
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(Not Specified)
abnormal coat appearance J:175295
abnormal hair growth J:175295
abnormal retina morphology J:175295
abnormal retinal pigmentation J:175295
increased carbon dioxide production J:175295
increased energy expenditure J:175295
increased oxygen consumption J:175295
sparse hair J:175295
Achetm1.1Hssh/Achetm1.1Hssh
(involves: 129S4/SvJae * C57BL/6)
abnormal body temperature homeostasis J:140622
abnormal sympathetic nervous system physiology J:140622
adipose tissue phenotype J:140622
decreased body temperature J:140622
decreased survivor rate J:140622
decreased white adipose tissue amount J:140622
premature death J:140622
slow postnatal weight gain J:140622
tremors J:140622
Achetm1.1Pata/Achetm1.1Pata
(involves: 129X1/SvJ * C57BL/6)
abnormal platelet physiology J:132775
growth/size/body phenotype J:132775
muscle weakness J:132775
reproductive system phenotype J:132775
tremors J:132775
Achetm1.1Pata/Achetm1.1Pata
(involves: 129X1/SvJ)
abnormal respiration J:147483
abnormal respiratory function J:147483
decreased body temperature J:147483
decreased body weight J:147483
decreased pulmonary ventilation J:147483
decreased tidal volume J:147483
increased physiological sensitivity to xenobiotic J:147483
increased pulmonary ventilation J:147483
increased tidal volume J:147483
Achetm1Loc/Achetm1Loc
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
abnormal cerebrum morphology J:76453
abnormal gait J:76453
abnormal posture J:76453
circling J:76453
complete postnatal lethality J:76453
decreased body weight J:76453
delayed ear emergence J:76453
eyelids fail to open J:76453
impaired righting response J:76453
partial prenatal lethality J:76453
tremors J:76453
Achetm1Loc/Achetm1Loc
(involves: 129S1/Sv * 129X1/SvJ)
abnormal physiological response to xenobiotic J:130048
increased physiological sensitivity to xenobiotic J:130048
increased sensitivity to xenobiotic induced morbidity/mortality J:130048
Achetm1Pata/Achetm1Pata
(involves: 129X1/SvJ * C57BL/6)
no phenotypic analysis J:132775
Achetm2Pata/Achetm2Pata
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
growth/size/body phenotype J:132775
muscle weakness J:132775
reproductive system phenotype J:132775
tremors J:132775
Achetm3Pata/Achetm3Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB)
abnormal vocalization J:147855
decreased body size J:147855
weakness J:147855
Achetm4.1Pata/Achetm4.1Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB * FVB/N)
behavior/neurological phenotype J:147855
homeostasis/metabolism phenotype J:147855
muscle weakness J:147855
Achetm4Pata/Achetm4Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB)
abnormal vocalization J:147855
decreased body size J:147855
decreased grip strength J:147855
impaired exercise endurance J:147855
infertility J:147855
muscle weakness J:147855
seizures J:147855
weakness J:147855
Achetm4Pata/Achetm4Pata
(involves: 129X1/SvJ)
abnormal involuntary movement J:147425
abnormal posture J:147425
abnormal respiration J:147483
abnormal respiratory function J:147483
abnormal vocalization J:147425
decreased body size J:147425
decreased body temperature J:147483
decreased body weight J:147483, J:147425
decreased grip strength J:147425
decreased tidal volume J:147483
hunched posture J:147425
increased physiological sensitivity to xenobiotic J:147483
increased pulmonary ventilation J:147483
increased tidal volume J:147483
infertility J:147425
Achetm4Pata/Achetm4Pata
Prima1tm1Vebe/Prima1tm1Vebe

(involves: 129X1/SvJ * C57BL/6 * DBA/2)
abnormal body temperature homeostasis J:147425
decreased body weight J:147425
Ackr1tm1Pogo/Ackr1tm1Pogo
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal bone marrow cavity morphology J:122127
abnormal trabecular bone morphology J:122127
increased bone mineral density J:122127
Ackr1tm1Scp/Ackr1tm1Scp
(involves: 129P2/OlaHsd * C57BL/6)
increased inflammatory response J:64222
Ackr1tm1Scp/Ackr1tm1Scp
(involves: 129P2/OlaHsd)
abnormal circulating chemokine level J:162629
Ackr1tm1Skmz/Ackr1tm1Skmz
(involves: 129P2/OlaHsd * C57BL/6J)
abnormal chemokine level J:82938
abnormal homeostasis J:82938
Ackr2tm1Gjg/Ackr2tm1Gjg
(involves: 129/Sv * C57BL/6)
dermatitis J:97607
increased inflammatory response J:97806
mortality/aging J:97806
reproductive system phenotype J:97806
Ackr3tm1.1Dsr/Ackr3tm1.1Dsr
(involves: 129S/SvEv * BALB/cJ * C57BL/6)
abnormal atrioventricular cushion morphology J:167833
abnormal cardiovascular system physiology J:167833
abnormal heart and great artery attachment J:167833
abnormal semilunar valve morphology J:167833
aortic valve stenosis J:167833
complete neonatal lethality J:167833
cyanosis J:167833
dilated heart atrium J:167833
enlarged heart J:167833
hemorrhage J:167833
overriding aortic valve J:167833
partial perinatal lethality J:167833
perimembraneous ventricular septal defect J:167833
pulmonary valve stenosis J:167833
respiratory distress J:167833
thick aortic valve J:167833
thick pulmonary valve J:167833
Ackr3tm1.1Fma/Ackr3+
(involves: BALB/cJ * C57BL/6)
abnormal aortic valve morphology J:124878
Ackr3tm1.1Fma/Ackr3tm1.1Fma
(involves: BALB/cJ * C57BL/6)
abnormal aortic valve morphology J:124878
abnormal heart morphology J:124878
abnormal outflow tract development J:124878
abnormal pulmonary valve morphology J:124878
atrial septal defect J:124878
calcified aortic valve J:124878
decreased marginal zone B cell number J:124878
digestive/alimentary phenotype J:124878
dilated heart right ventricle J:124878
nervous system phenotype J:124878
overriding aortic valve J:124878
partial neonatal lethality